<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Antioxidants (Basel)</journal-id>
<journal-id journal-id-type="iso-abbrev">Antioxidants (Basel)</journal-id>
<journal-id journal-id-type="publisher-id">antioxidants</journal-id>
<journal-title-group>
<journal-title>Antioxidants</journal-title>
</journal-title-group>
<issn pub-type="epub">2076-3921</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31581464</article-id>
<article-id pub-id-type="pmc">6826639</article-id>
<article-id pub-id-type="doi">10.3390/antiox8100436</article-id>
<article-id pub-id-type="publisher-id">antioxidants-08-00436</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Say NO to ROS: Their Roles in Embryonic Heart Development and Pathogenesis of Congenital Heart Defects in Maternal Diabetes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Engineer</surname>
<given-names>Anish</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4215-6017</contrib-id>
<name>
<surname>Saiyin</surname>
<given-names>Tana</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greco</surname>
<given-names>Elizabeth R.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9739-2765</contrib-id>
<name>
<surname>Feng</surname>
<given-names>Qingping</given-names>
</name>
<xref ref-type="corresp" rid="c1-antioxidants-08-00436">*</xref>
</contrib>
</contrib-group>
<aff id="af1-antioxidants-08-00436">Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, ON N6A 5C1, Canada; <email>aengine@uwo.ca</email> (A.E.); <email>tsaiyin@uwo.ca</email> (T.S.); <email>egreco5@uwo.ca</email> (E.R.G.)</aff>
<author-notes>
<corresp id="c1-antioxidants-08-00436"><label>*</label>Correspondence: <email>qfeng@uwo.ca</email>; Tel.: +1-519-850-2989</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2019</year>
</pub-date>
<volume>8</volume>
<issue>10</issue>
<elocation-id>436</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Congenital heart defects (CHDs) are the most prevalent and serious birth defect, occurring in 1% of all live births. Pregestational maternal diabetes is a known risk factor for the development of CHDs, elevating the risk in the child by more than four-fold. As the prevalence of diabetes rapidly rises among women of childbearing age, there is a need to investigate the mechanisms and potential preventative strategies for these defects. In experimental animal models of pregestational diabetes induced-CHDs, upwards of 50% of offspring display congenital malformations of the heart, including septal, valvular, and outflow tract defects. Specifically, the imbalance of nitric oxide (NO) and reactive oxygen species (ROS) signaling is a major driver of the development of CHDs in offspring of mice with pregestational diabetes. NO from endothelial nitric oxide synthase (eNOS) is crucial to cardiogenesis, regulating various cellular and molecular processes. In fact, deficiency in eNOS results in CHDs and coronary artery malformation. Embryonic hearts from diabetic dams exhibit eNOS uncoupling and oxidative stress. Maternal treatment with sapropterin, a cofactor of eNOS, and antioxidants such as N-acetylcysteine, vitamin E, and glutathione as well as maternal exercise have been shown to improve eNOS function, reduce oxidative stress, and lower the incidence CHDs in the offspring of mice with pregestational diabetes. This review summarizes recent data on pregestational diabetes-induced CHDs, and offers insights into the important roles of NO and ROS in embryonic heart development and pathogenesis of CHDs in maternal diabetes.</p>
</abstract>
<kwd-group>
<kwd>congenital heart defects</kwd>
<kwd>pregestational diabetes</kwd>
<kwd>nitric oxide</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>eNOS</kwd>
<kwd>heart development</kwd>
<kwd>tetrahydrobiopterin</kwd>
<kwd>oxidative stress</kwd>
<kwd>antioxidant</kwd>
<kwd>exercise</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-antioxidants-08-00436" sec-type="intro">
<title>1. Introduction</title>
<p>Congenital heart defects (CHDs) are the most common structural birth defect, occurring in 1–5% of live births [<xref ref-type="bibr" rid="B1-antioxidants-08-00436">1</xref>,<xref ref-type="bibr" rid="B2-antioxidants-08-00436">2</xref>,<xref ref-type="bibr" rid="B3-antioxidants-08-00436">3</xref>]. Congenital heart disease is the leading cause of pediatric deaths in developed nations [<xref ref-type="bibr" rid="B4-antioxidants-08-00436">4</xref>]. Pregestational diabetes is an important risk factor of CHDs [<xref ref-type="bibr" rid="B5-antioxidants-08-00436">5</xref>]. While good glycemic control in diabetic mothers lowers the risk, the incidence of CHDs in their children is still higher than in the general population [<xref ref-type="bibr" rid="B6-antioxidants-08-00436">6</xref>]. Congenital malformations in the offspring of women with pregestational diabetes include defects of the limb, neural tube, and musculoskeletal systems. However, the predominant malformations are CHDs, which represent about 40% of the total malformations [<xref ref-type="bibr" rid="B7-antioxidants-08-00436">7</xref>,<xref ref-type="bibr" rid="B8-antioxidants-08-00436">8</xref>]. Currently, 40% of women with diabetes are of reproductive age [<xref ref-type="bibr" rid="B9-antioxidants-08-00436">9</xref>]. The rapid increase of young adults with diabetes and prediabetes is alarming, and warrants further research to broaden our understanding of the pathogenesis of congenital cardiovascular malformations and their prevention.</p>
<p>To understand pathogenesis of CHDs in maternal diabetes, various experimental approaches have been employed. In animal models, diabetes can be induced via many techniques, including diet, drugs, surgery, or genetic alterations. A common, established method for the generation of a type 1 diabetes (T1D) model in rodents is streptozotocin (STZ) administration [<xref ref-type="bibr" rid="B10-antioxidants-08-00436">10</xref>,<xref ref-type="bibr" rid="B11-antioxidants-08-00436">11</xref>]. This chemical agent is a glucose analogue, which is taken up by pancreatic β-cells via the glucose transporter 2 (GLUT2). STZ within the cell causes DNA damage, oxidative stress, and ultimately results in β-cell death [<xref ref-type="bibr" rid="B12-antioxidants-08-00436">12</xref>]. This depletion of pancreatic β-cells and thereby insulin supply recapitulates T1D in humans. Animal studies analyzing heart development in this model of pregestational maternal diabetes indicate that reactive oxygen species (ROS) are critical players in mediating maladaptive heart development, leading to CHDs [<xref ref-type="bibr" rid="B13-antioxidants-08-00436">13</xref>,<xref ref-type="bibr" rid="B14-antioxidants-08-00436">14</xref>,<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>,<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>,<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>,<xref ref-type="bibr" rid="B18-antioxidants-08-00436">18</xref>,<xref ref-type="bibr" rid="B19-antioxidants-08-00436">19</xref>,<xref ref-type="bibr" rid="B20-antioxidants-08-00436">20</xref>,<xref ref-type="bibr" rid="B21-antioxidants-08-00436">21</xref>,<xref ref-type="bibr" rid="B22-antioxidants-08-00436">22</xref>,<xref ref-type="bibr" rid="B23-antioxidants-08-00436">23</xref>,<xref ref-type="bibr" rid="B24-antioxidants-08-00436">24</xref>,<xref ref-type="bibr" rid="B25-antioxidants-08-00436">25</xref>]. Oxidative stress, brought on by hyperglycemia, is not conducive to the development of cardiac progenitors as it results in the oxidation and inactivation of many molecules and enzymes necessary for cardiogenesis. Emerging data suggests a protective role of endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) in reducing the incidence of the pathogenesis of diabetes-related CHDs. In this review, we examine the etiology and epidemiology of pregestational diabetes-induced CHDs and summarize numerous rodent studies looking at this link, while focusing on the pathophysiological role of ROS and eNOS uncoupling.</p>
</sec>
<sec id="sec2-antioxidants-08-00436">
<title>2. Congenital Heart Defects</title>
<sec id="sec2dot1-antioxidants-08-00436">
<title>2.1. Epidemiology and Classification</title>
<p>It is estimated that 257,000 Canadians and about 2 million Americans are living with a CHD [<xref ref-type="bibr" rid="B26-antioxidants-08-00436">26</xref>,<xref ref-type="bibr" rid="B27-antioxidants-08-00436">27</xref>]. Approximately 40,000 infants are diagnosed with a CHD each year in the US, and a quarter of these patients will need invasive treatment in the first year of life [<xref ref-type="bibr" rid="B3-antioxidants-08-00436">3</xref>]. CHDs arise from perturbations in complex cellular and molecular processes underlying embryonic heart development. Adverse genetic and environmental factors can impede normal cardiogenesis and increase the likelihood of CHDs. Several types of malformations can result from missteps during this process. Defects of the septum, such as a ventricular septal defect (VSD) permits mixing of de-oxygenated and oxygenated blood. Major malformations such as transposition of the great arteries (TGA) can involve multiple structures of the heart [<xref ref-type="bibr" rid="B2-antioxidants-08-00436">2</xref>]. Outflow tract defects such as persistent truncus arteriosus (PTA) and malformations in the valves of the heart can also arise from improper cardiogenesis. These defects compromise the function of the cardiovascular system by reducing the ability of the heart to adequately perfuse the body with oxygenated blood.</p>
<p>The International Classification of Diseases (ICD-10) classifies 25 distinct types of anatomical or hemodynamic CHDs [<xref ref-type="bibr" rid="B3-antioxidants-08-00436">3</xref>]. CHDs can be categorized based on severity of the morphological lesions and functional consequences. Conventionally, CHDs are grouped into three categories: mild, moderate, and severe. The majority of CHD cases can be considered mild. The cardiac defects in these patients would be largely asymptomatic, often undergoing spontaneous resolution [<xref ref-type="bibr" rid="B28-antioxidants-08-00436">28</xref>]. Moderate CHDs are more complex and require expert care, but are less intensive than the severe cases. Severe CHDs include the univentricular heart, heterotaxy, conotruncal defects, and atrioventricular canal defects, affecting one third of all patients with cardiac anomalies [<xref ref-type="bibr" rid="B29-antioxidants-08-00436">29</xref>]. Expert cardiologic care and intervention are required for these patients in the first year of life. Accordingly, survival rate is dependent on the severity of the disease. This rate is estimated to be 98% for patients with a mild CHD, whereas it is only 56% for patients with a severe CHD [<xref ref-type="bibr" rid="B30-antioxidants-08-00436">30</xref>]. Surgical procedures to correct congenital malformations of the heart do not always have high efficacy [<xref ref-type="bibr" rid="B31-antioxidants-08-00436">31</xref>]. Individuals with CHDs commonly require multiple operations and drug therapy, and are at an elevated risk for arrhythmias, bacterial endocarditis, and heart failure, placing a large burden on the health care system [<xref ref-type="bibr" rid="B32-antioxidants-08-00436">32</xref>]. Patients often have extracardiac co-morbidities, such as neurological deficits, which affect quality of life [<xref ref-type="bibr" rid="B33-antioxidants-08-00436">33</xref>]. The prevalence of neurodevelopmental disabilities in the population of patients with CHDs ranges from 10% to over 50% depending on the severity of the lesion and whether pediatric surgery was required [<xref ref-type="bibr" rid="B34-antioxidants-08-00436">34</xref>]. The spectrum of these abnormalities includes intellectual disability, autism spectrum disorder, and deficits in language, motor, and social skills [<xref ref-type="bibr" rid="B35-antioxidants-08-00436">35</xref>]. In fact, attention deficit hyperactivity disorder is three to four times more prevalent in children with a CHD [<xref ref-type="bibr" rid="B36-antioxidants-08-00436">36</xref>]. CHD-related hospitalizations in the US have steadily risen, with a financial burden of $6.1 billion per annum [<xref ref-type="bibr" rid="B37-antioxidants-08-00436">37</xref>]. Therefore, it is vital that research be conducted into how these malformations develop to be able to identify potential preventative interventions.</p>
</sec>
<sec id="sec2dot2-antioxidants-08-00436">
<title>2.2. Risk Factors Associated with CHDs</title>
<p>Risk factors associated with CHDs include genetic and nongenetic factors. While chromosome abnormalities and genetic mutations account for 15% of reported cases, nongenetic or environmental factors are associated with the majority of CHDs seen in the clinic [<xref ref-type="bibr" rid="B38-antioxidants-08-00436">38</xref>]. Genetic factors include mutations in key transcription factors, such as <italic>TBX5</italic>, <italic>NKX2.5</italic>, that govern heart development, and chromosomal abnormalities, such as trisomy 21 [<xref ref-type="bibr" rid="B39-antioxidants-08-00436">39</xref>,<xref ref-type="bibr" rid="B40-antioxidants-08-00436">40</xref>]. Nongenetic factors are various environmental insults during pregnancy that compromise developmental pathways in the embryo. The nongenetic risk factors can include maternal diabetes, smoking, nicotine exposure, alcohol consumption, obesity, chlamydia or rubella infections, preeclampsia, and high altitude [<xref ref-type="bibr" rid="B41-antioxidants-08-00436">41</xref>,<xref ref-type="bibr" rid="B42-antioxidants-08-00436">42</xref>,<xref ref-type="bibr" rid="B43-antioxidants-08-00436">43</xref>,<xref ref-type="bibr" rid="B44-antioxidants-08-00436">44</xref>,<xref ref-type="bibr" rid="B45-antioxidants-08-00436">45</xref>,<xref ref-type="bibr" rid="B46-antioxidants-08-00436">46</xref>,<xref ref-type="bibr" rid="B47-antioxidants-08-00436">47</xref>,<xref ref-type="bibr" rid="B48-antioxidants-08-00436">48</xref>,<xref ref-type="bibr" rid="B49-antioxidants-08-00436">49</xref>]. For instance, there was an exposure–response relationship between increasing body mass index in pregnant women and CHD incidence in their children. In fact, children of severely obese women were at a 1.94 times greater risk of having tetralogy of Fallot [<xref ref-type="bibr" rid="B44-antioxidants-08-00436">44</xref>]. Pregestational diabetes is another risk factor for congenital heart disease [<xref ref-type="bibr" rid="B50-antioxidants-08-00436">50</xref>], and has been observed to increase the risk of CHDs in human populations by more than four-fold [<xref ref-type="bibr" rid="B5-antioxidants-08-00436">5</xref>,<xref ref-type="bibr" rid="B6-antioxidants-08-00436">6</xref>,<xref ref-type="bibr" rid="B7-antioxidants-08-00436">7</xref>,<xref ref-type="bibr" rid="B8-antioxidants-08-00436">8</xref>,<xref ref-type="bibr" rid="B51-antioxidants-08-00436">51</xref>,<xref ref-type="bibr" rid="B52-antioxidants-08-00436">52</xref>,<xref ref-type="bibr" rid="B53-antioxidants-08-00436">53</xref>].</p>
</sec>
</sec>
<sec id="sec3-antioxidants-08-00436">
<title>3. Pregestational Diabetes and CHDs</title>
<sec id="sec3dot1-antioxidants-08-00436">
<title>3.1. Increasing Prevalence of Pregestational Diabetes</title>
<p>Currently, an estimated 451 million people are living with diabetes, and the incidence of this condition is increasing at a rate of 10 million people per year. It is projected that by the year 2040, approximately 693 million people will be affected [<xref ref-type="bibr" rid="B54-antioxidants-08-00436">54</xref>]. In Canada, more than 11 million people are living with diabetes or prediabetes. Type 1 diabetes (T1D) is characterized by autoimmune destruction of pancreatic β-cells, resulting in a lack of insulin production; whereas type 2 diabetes (T2D) is the result of insulin resistance and usually has a later onset, but is much more prevalent [<xref ref-type="bibr" rid="B55-antioxidants-08-00436">55</xref>]. The incidence of both T1D and T2D is increasing in youth aged 10–19 years [<xref ref-type="bibr" rid="B56-antioxidants-08-00436">56</xref>,<xref ref-type="bibr" rid="B57-antioxidants-08-00436">57</xref>]. In fact, T2D among the adolescent population in the US has increased 31% between 2001 and 2009, with prediabetes rising from 9% to 23% [<xref ref-type="bibr" rid="B3-antioxidants-08-00436">3</xref>]. Importantly, 40% of women with diabetes are of reproductive age [<xref ref-type="bibr" rid="B9-antioxidants-08-00436">9</xref>], and the incidence of T2D is rapidly increasing in this population [<xref ref-type="bibr" rid="B54-antioxidants-08-00436">54</xref>]. It is estimated that 1 in 5 women are overweight/obese during pregnancy [<xref ref-type="bibr" rid="B58-antioxidants-08-00436">58</xref>]. In the U.S alone, there was a 37% increase in the number of deliveries affected by pregestational or prepregnancy diabetes between 2000 and 2010 [<xref ref-type="bibr" rid="B59-antioxidants-08-00436">59</xref>]. A study of trends in delivery hospitalizations between 1994 and 2004 found a diabetes diagnosis in 4.3 out of 100 deliveries, of which T2D saw the largest increase (367%) in diagnoses during this time period [<xref ref-type="bibr" rid="B60-antioxidants-08-00436">60</xref>]. Other studies have shown an increase in pregnancies complicated with T1D and T2D by 44% and 90%, respectively in a 15 year period between 1998 and 2013 [<xref ref-type="bibr" rid="B61-antioxidants-08-00436">61</xref>].</p>
</sec>
<sec id="sec3dot2-antioxidants-08-00436">
<title>3.2. CHDs and Fetal Heart Abnormalities Associated with Pregestational Diabetes</title>
<p>A spectrum of cardiac defects is present in the offspring of women with pregestational diabetes, and ranges from minor structural malformations, such as atrial septal defect (ASD), to major morphological abnormalities, including tetralogy of Fallot [<xref ref-type="bibr" rid="B5-antioxidants-08-00436">5</xref>,<xref ref-type="bibr" rid="B62-antioxidants-08-00436">62</xref>,<xref ref-type="bibr" rid="B63-antioxidants-08-00436">63</xref>]. In a national population-based pregnancy cohort in England, Wales, and Northern Ireland, similar rates of congenital malformations were reported between T1D and T2D, 4.8% and 4.3%, respectively [<xref ref-type="bibr" rid="B64-antioxidants-08-00436">64</xref>]. In addition, it was found that 40% of infants born to diabetic mothers have hypertrophic cardiomyopathy, and case reports indicate that fetal death and stillbirth results from this condition in diabetic pregnancy [<xref ref-type="bibr" rid="B62-antioxidants-08-00436">62</xref>,<xref ref-type="bibr" rid="B65-antioxidants-08-00436">65</xref>,<xref ref-type="bibr" rid="B66-antioxidants-08-00436">66</xref>,<xref ref-type="bibr" rid="B67-antioxidants-08-00436">67</xref>,<xref ref-type="bibr" rid="B68-antioxidants-08-00436">68</xref>]. It has also been demonstrated that diabetic pregnancy results in reduced fetal cardiac diastolic function [<xref ref-type="bibr" rid="B69-antioxidants-08-00436">69</xref>], as well as altered heart rate variability and fetal acidaemia [<xref ref-type="bibr" rid="B70-antioxidants-08-00436">70</xref>]. During development, a higher fetal heart rate has been reported by cardiotocographic analysis from the first to the third trimester in pregnancies complicated with pregestational diabetes [<xref ref-type="bibr" rid="B71-antioxidants-08-00436">71</xref>,<xref ref-type="bibr" rid="B72-antioxidants-08-00436">72</xref>]. Accordingly, offspring of these women also have an altered QRS complex [<xref ref-type="bibr" rid="B73-antioxidants-08-00436">73</xref>]. In addition to modifying CHD risk and cardiac function, emerging longitudinal data suggests that adult metabolic and cardiovascular disorders are also in-part attributable to physiological insults in fetal life [<xref ref-type="bibr" rid="B74-antioxidants-08-00436">74</xref>,<xref ref-type="bibr" rid="B75-antioxidants-08-00436">75</xref>]. Adverse uterine environments, including maternal obesity, diabetes, undernutrition, and stress, can compromise embryonic development, reprogramming the epigenetic landscape [<xref ref-type="bibr" rid="B76-antioxidants-08-00436">76</xref>]. These adverse outcomes are largely dependent on glycemic control during the first seven weeks of pregnancy, therefore, effective interventions must be able to protect this early developmental period.</p>
<p>The main focus of healthcare management is to maintain glycemic control, predominantly through the use of medications such as insulin and metformin. These drugs are not teratogenic, but their long-term effects on children’s health are not well understood. Current pharmacologic therapies have shortcomings that reduce their potential to prevent adverse fetal outcomes. For example, patient compliance and maintenance are major factors that can impact efficacy and glycaemic control in pregnant women with diabetes [<xref ref-type="bibr" rid="B77-antioxidants-08-00436">77</xref>]. In addition, pregnancy can exacerbate and complicate diabetes management, usually requiring higher dosing of medication. As prevalence of diabetes is rapidly rising in low- to middle-income countries, there is also concern for adequate access to prenatal care and antidiabetic drugs [<xref ref-type="bibr" rid="B78-antioxidants-08-00436">78</xref>]. Even with access to healthcare and medications, studies have found that glycemic control alone does not completely eliminate the risk for adverse events, and CHD incidence in the offspring of diabetic women has remained unchanged, showing little improvement [<xref ref-type="bibr" rid="B79-antioxidants-08-00436">79</xref>,<xref ref-type="bibr" rid="B80-antioxidants-08-00436">80</xref>,<xref ref-type="bibr" rid="B81-antioxidants-08-00436">81</xref>,<xref ref-type="bibr" rid="B82-antioxidants-08-00436">82</xref>]. Thus research must be conducted to find alternate interventions that support current treatment practices, while remaining safe and accessible. To this date, the underlying molecular mechanisms of diabetic teratogenesis are not fully understood. Signaling pathways such as Notch, Wnt, transforming growth factor-beta (TGFβ) and hypoxia-inducing factor (HIF1α) have been implicated in the pathogenesis of CHDs in maternal diabetes. Oxidative damage is largely believed to be at the root of cellular and molecular changes leading to the development of CHDs. Additionally, eNOS-derived NO is an important signaling molecule in early embryonic heart development. eNOS dysfunction and uncoupling also contribute to oxidative stress and CHD pathogenesis.</p>
</sec>
</sec>
<sec id="sec4-antioxidants-08-00436">
<title>4. Embryonic Heart Development: Role of eNOS</title>
<sec id="sec4dot1-antioxidants-08-00436">
<title>4.1. Heart Morphogenesis</title>
<p>The heart is the first fully functional organ to form during embryogenesis, and its development is orchestrated by an interplay of conserved transcription factors that control growth, morphogenesis, and contractility [<xref ref-type="bibr" rid="B83-antioxidants-08-00436">83</xref>]. Cardiac development involves the harmonic combination of three pools of progenitor cells, that when present in a specific spatial and temporal orientation together, form a self-excitable, four-chambered vascular pump [<xref ref-type="bibr" rid="B84-antioxidants-08-00436">84</xref>]. Heart development commences at week 3 of human embryogenesis, corresponding to embryonic day 7.5 (E7.5) in the mouse, with the formation of a cardiac crescent and subsequent heart tube from cells of the anterior lateral mesoderm [<xref ref-type="bibr" rid="B85-antioxidants-08-00436">85</xref>]. This first wave of cardiac progenitors has been termed the first heart field (FHF), forming a concentric inner layer of endocardial cells and outer layer of myocardial cells separated with extracellular matrix, also known as cardiac jelly [<xref ref-type="bibr" rid="B86-antioxidants-08-00436">86</xref>]. The FHF-derived heart tube specifically contributes to parts of the atria and the left ventricle of the mature heart. The primitive heart tube is elongated at its poles by the addition of proliferative cells coming from the adjacent splanchnic pharyngeal mesoderm. This consecutive wave of myoblasts has been termed the second heart field (SHF), and contributes to the rightward looping morphogenesis of the tube, whereby primitive chambers of the heart can be distinguished [<xref ref-type="bibr" rid="B87-antioxidants-08-00436">87</xref>]. These cells elongate the heart tube by migrating to its arterial and venous poles, progressively adding new myocardium and endocardium to the outflow and inflow tracts, respectively. Chamber development by ballooning, muscularization and fusion of endocardial cushions, ventricular myocardialization and septation, outflow tract and cardiac valve development are completed thereafter, with the addition of cardiac neural crest cells (CNCs) migrating from the dorsal neural tube [<xref ref-type="bibr" rid="B88-antioxidants-08-00436">88</xref>]. Recently, single-cell RNA sequencing to map the transcriptome of the developing human heart revealed that cardiomyocytes exhibit differential gene expression signatures with chamber-specific clusters as early as 5 weeks into embryogenesis [<xref ref-type="bibr" rid="B89-antioxidants-08-00436">89</xref>]. A number of conserved transcription factors govern the complex process of cardiac development. Mutations in <italic>GATA4</italic>, <italic>NKX2.5</italic> and <italic>TBX5</italic>, and <italic>MEF2</italic> are associated with CHDs in humans [<xref ref-type="bibr" rid="B90-antioxidants-08-00436">90</xref>,<xref ref-type="bibr" rid="B91-antioxidants-08-00436">91</xref>,<xref ref-type="bibr" rid="B92-antioxidants-08-00436">92</xref>,<xref ref-type="bibr" rid="B93-antioxidants-08-00436">93</xref>]. Specific spatiotemporal interaction and crosstalk between these factors are essential to control cardiogenic gene programs driving normal heart development [<xref ref-type="bibr" rid="B94-antioxidants-08-00436">94</xref>]. Cardiac development is therefore a complex spatiotemporal process, and a misstep in this orchestration could lead to a CHD.</p>
</sec>
<sec id="sec4dot2-antioxidants-08-00436">
<title>4.2. Nitric Oxide Signaling</title>
<p>NO was initially discovered in the vascular endothelium as an endothelium-derived relaxing factor (EDRF) by Furchgott and Zawadzki in 1980 [<xref ref-type="bibr" rid="B95-antioxidants-08-00436">95</xref>]. NO is a lipophilic, small, gaseous molecule that has numerous roles in biological signaling processes and, most notably, serves as a potent vasodilator that regulates vascular function and blood pressure [<xref ref-type="bibr" rid="B96-antioxidants-08-00436">96</xref>,<xref ref-type="bibr" rid="B97-antioxidants-08-00436">97</xref>]. NO production within the cell is accomplished by the enzyme nitric oxide synthase (NOS), which catalyzes the conversion of L-arginine into nitric oxide through a NADPH-dependent reaction. Three isoforms of this enzyme, neuronal (nNOS, NOS1), cytokine-inducible (iNOS, NOS2), and endothelial (eNOS, NOS3) are distinctly expressed in mammalian cells and produce NO in a tissue-specific manner [<xref ref-type="bibr" rid="B98-antioxidants-08-00436">98</xref>]. nNOS is constitutively expressed in neurons of the central and peripheral nervous system, whereas iNOS is expressed in cells of the immune system and produces high levels of nitric oxide associated with inflammatory processes. eNOS is membrane-bound and calcium-sensitive, expressed in endothelial and myocardial cells, located on chromosome 7 in humans [<xref ref-type="bibr" rid="B99-antioxidants-08-00436">99</xref>]. They are homodimeric, haem-containing globular proteins, with an N-terminal oxygenase domain and a C-terminal reductase domain, which are linked by a calmodulin-binding sequence. The dimer produces NO in the coupled state and requires Ca<sup>2+</sup>/calmodulin, flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and tetrahydrobiopterin (BH4) as cofactors [<xref ref-type="bibr" rid="B98-antioxidants-08-00436">98</xref>]. Calcium-activated calmodulin initiates the election transfer to produce NO, which, when produced, acts on soluble guanylyl cyclase to catalyze the formation of the second messenger, cyclic guanosine monophosphate (cGMP). Downstream targets of cGMP include protein kinases (PKGs), ion channels, and cyclic nucleotide phosphodiesterases (PDEs) [<xref ref-type="bibr" rid="B100-antioxidants-08-00436">100</xref>]. Activation or inhibition of protein function via S-nitrosylation is also a downstream effect of NO. Interestingly, eNOS can be itself S-nitrosylated, reducing its activity [<xref ref-type="bibr" rid="B101-antioxidants-08-00436">101</xref>]. Phosphorylation of eNOS at serine-1177 by Akt (protein kinase B) activates the enzyme, which itself is active when phosphorylated. NO production via this PI3K/Akt/eNOS pathway represents a highly regulated biological process involved in endothelial cell permeability, vascular smooth muscle relaxation, calcium handling, immune regulation, and neurotransmission [<xref ref-type="bibr" rid="B97-antioxidants-08-00436">97</xref>,<xref ref-type="bibr" rid="B102-antioxidants-08-00436">102</xref>].</p>
</sec>
<sec id="sec4dot3-antioxidants-08-00436">
<title>4.3. Tetrahydrobiopterin and eNOS Coupling</title>
<p>The pteridine (6R) 5,6,7,8-tetrahydrobiopterin (BH4) is an antioxidant and cofactor for many metabolic enzymes involved in the production of neurotransmitters and NO. As a cofactor, its heterocyclic ring structure functions to facilitate complex chemical reactions in a wide variety of biological processes [<xref ref-type="bibr" rid="B103-antioxidants-08-00436">103</xref>]. BH4 is essential for NOS-mediated NO synthesis, by all three isoforms, and serves both biochemical and structural functions [<xref ref-type="bibr" rid="B103-antioxidants-08-00436">103</xref>]. It is required for eNOS homo-dimer stabilization and is an allosteric modulator of <sc>l</sc>-arginine binding to the active site [<xref ref-type="bibr" rid="B104-antioxidants-08-00436">104</xref>]. BH4 participates in the biochemical formation of NO from O<sub>2</sub> by donating an electron for the conversion of <sc>l</sc>-arginine to <sc>l</sc>-citrulline [<xref ref-type="bibr" rid="B105-antioxidants-08-00436">105</xref>]. It “couples” the heme reduction to NO synthesis and acts as a sequential one-electron reductant and oxidant [<xref ref-type="bibr" rid="B98-antioxidants-08-00436">98</xref>].</p>
<p>BH4 production, either through de novo synthesis or recycling, promotes eNOS function, generating NO [<xref ref-type="bibr" rid="B106-antioxidants-08-00436">106</xref>]. In fact, diminished levels of BH4 or depletion of <sc>l</sc>-arginine can uncouple the eNOS dimer, rendering it incapable of producing NO, instead generating oxygen-derived free radicals [<xref ref-type="bibr" rid="B107-antioxidants-08-00436">107</xref>]. Similarly, in states of oxidative stress, this process is insulted at many levels, sustaining the oxidative environment and leading to cellular dysfunction. The production of ROS is often amplified because of a positive-feedback loop; ROS generates more ROS. For example, ROS causes the release of zinc from GTP cyclohydrase 1 (GTPCH-1), a rate-limiting enzyme in BH4 synthesis, rendering it less functional [<xref ref-type="bibr" rid="B108-antioxidants-08-00436">108</xref>]. Consequently, the intracellular levels of BH4 decline, and eNOS is left without a cofactor, triggering its uncoupling and superoxide production. This superoxide anion participates in a rapid reaction with low levels of NO in the cell and forms the peroxynitrite anion (ONOO<sup>−</sup>) (<xref ref-type="fig" rid="antioxidants-08-00436-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B109-antioxidants-08-00436">109</xref>]. This species is normally in equilibrium with peroxynitrous acid (ONOOH), which can decay and form ONOOH<sup>•</sup>, another reactive radical. Proteins are especially vulnerable to modification by the peroxynitrite system, as it incurs covalent changes to the amino acid residues cysteine, methionine, tryptophan, and tyrosine [<xref ref-type="bibr" rid="B110-antioxidants-08-00436">110</xref>]. ONOO<sup>−</sup> specifically inactivates GTPCH-1, decreasing de novo BH4 synthesis, and the additional oxidative stress furthers the oxidation of BH4 into BH2 [<xref ref-type="bibr" rid="B108-antioxidants-08-00436">108</xref>]. BH2 is unable to couple eNOS, and competes with BH4 for eNOS binding, exacerbating the superoxide production. Mice lacking GTPCH-1 in the endothelium display significantly lower BH4 levels associated with eNOS uncoupling and increased ROS production, resulting in impairment of vasodilation [<xref ref-type="bibr" rid="B106-antioxidants-08-00436">106</xref>].</p>
<p>Another enzyme inactivated by O<sub>2</sub><sup>•−</sup> and ONOO<sup>−</sup> is dihydrofolate reductase (DHFR), responsible for the recycling of dihydrobiopterin (BH2) back to BH4 (<xref ref-type="fig" rid="antioxidants-08-00436-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B105-antioxidants-08-00436">105</xref>,<xref ref-type="bibr" rid="B111-antioxidants-08-00436">111</xref>]. Experiments done in <italic>Escherichia Coli</italic> (<italic>E. coli</italic>) demonstrate peroxynitrite-induced alterations to the catalytic site of DHFR, resulting in functional compromise [<xref ref-type="bibr" rid="B112-antioxidants-08-00436">112</xref>]. Therefore, both the salvage and de novo synthesis pathways are crippled due to ROS, furthering the oxidative environment [<xref ref-type="bibr" rid="B113-antioxidants-08-00436">113</xref>]. The relationship between eNOS function and diabetes has been well established. Endothelial dysfunction is a common consequence of diabetes and is mediated by oxidative stress-induced eNOS uncoupling [<xref ref-type="bibr" rid="B114-antioxidants-08-00436">114</xref>,<xref ref-type="bibr" rid="B115-antioxidants-08-00436">115</xref>,<xref ref-type="bibr" rid="B116-antioxidants-08-00436">116</xref>]. Previous studies indicate that dissolution of the eNOS dimer also occurs in aging vessels and in cardiovascular disease states, such as hypertension, ischemia-reperfusion injury, and heart failure [<xref ref-type="bibr" rid="B117-antioxidants-08-00436">117</xref>,<xref ref-type="bibr" rid="B118-antioxidants-08-00436">118</xref>,<xref ref-type="bibr" rid="B119-antioxidants-08-00436">119</xref>]. Treatment with BH4 has been shown to recouple eNOS and partially improve vascular endothelial function in diabetes [<xref ref-type="bibr" rid="B103-antioxidants-08-00436">103</xref>,<xref ref-type="bibr" rid="B120-antioxidants-08-00436">120</xref>]. Clinical studies also show the benefits of BH4 therapy in improving endothelial dysfunction, vasodilation, and lowering blood pressure in clinical settings of hypertension and hypercholesterolemia [<xref ref-type="bibr" rid="B121-antioxidants-08-00436">121</xref>,<xref ref-type="bibr" rid="B122-antioxidants-08-00436">122</xref>]. However, acute intracoronary infusion of BH4 to patients with coronary disease showed no significant improvement in coronary vascular reactivity or microvascular endothelial function in the heart [<xref ref-type="bibr" rid="B123-antioxidants-08-00436">123</xref>]. Additionally, oral BH4 treatment for 2 to 6 weeks augments total biopterin levels in patients awaiting for coronary bypass surgery, but has no net effects on vascular redox state or endothelial function due to rapid oxidation of BH4 [<xref ref-type="bibr" rid="B124-antioxidants-08-00436">124</xref>]. Thus, the type of cardiovascular disease that benefits from BH4 therapy remains to be investigated.</p>
</sec>
<sec id="sec4dot4-antioxidants-08-00436">
<title>4.4. Role of eNOS in Heart Development</title>
<p>During embryogenesis, eNOS is expressed in the developing heart, and its expression has been shown to be vital for embryonic heart development [<xref ref-type="bibr" rid="B102-antioxidants-08-00436">102</xref>,<xref ref-type="bibr" rid="B125-antioxidants-08-00436">125</xref>]. In mice, expression of the synthase starts at E9.5 in the endothelium and cardiomyocyte precursors of the heart tube, and peaks at E13.5, after which it begins to decline, but remains detectable at birth and into postnatal development [<xref ref-type="bibr" rid="B102-antioxidants-08-00436">102</xref>]. The lung, liver, gastrointestinal tract, reproductive organs, and brain all express eNOS during their organogenesis [<xref ref-type="bibr" rid="B126-antioxidants-08-00436">126</xref>]. In vitro incubation of NOS inhibitors to embryonic stem cell-derived cardiomyocytes inhibited their maturation [<xref ref-type="bibr" rid="B126-antioxidants-08-00436">126</xref>]. Interestingly, mouse embryonic stem cells exogenously treated with a NO donor or transfected with NOS promoted their differentiation into cardiomyocytes, inducing the expression of cardiac-specific genes [<xref ref-type="bibr" rid="B127-antioxidants-08-00436">127</xref>]. Induced pluripotent stem cells and mouse E14.5 ventricular tissues in which eNOS are deficient show consistent transcriptome profiles, and particularly an up-regulation of glucose metabolism genes [<xref ref-type="bibr" rid="B128-antioxidants-08-00436">128</xref>]. Gata4, a transcription factor needed for cardiomyocyte specification and heart development, can modulate and increase the expression of eNOS by binding to its promoter region [<xref ref-type="bibr" rid="B129-antioxidants-08-00436">129</xref>]. The importance of eNOS in heart development has been showcased through the spectrum of cardiovascular anomalies seen in eNOS<sup>−/−</sup> mice. Embryonic deletion of nNOS or iNOS displays normal cardiac phenotypes, however eNOS-null mice have a high rate of CHDs in the offspring. These mice have increased postnatal mortality, impaired heart function, and significant elevations in embryonic apoptosis in the heart [<xref ref-type="bibr" rid="B125-antioxidants-08-00436">125</xref>]. In addition, they have valvular malformations, including bicuspid aortic valves (30–40% incidence) and underdeveloped mitral and tricuspid valves, which have significant regurgitation during systole along with aortic valve sclerosis and calcification [<xref ref-type="bibr" rid="B130-antioxidants-08-00436">130</xref>,<xref ref-type="bibr" rid="B131-antioxidants-08-00436">131</xref>,<xref ref-type="bibr" rid="B132-antioxidants-08-00436">132</xref>].</p>
<p>During embryonic development, eNOS-null mice have less Snail<sup>+</sup> mesenchymal cells in the endocardial cushions, suggesting impaired endocardial-to-mesenchymal transition (EndMT). This was coupled with significantly lower mRNA levels of genes involved in valve formation, such as <italic>Tgf-β</italic> and <italic>Bmp2</italic> [<xref ref-type="bibr" rid="B131-antioxidants-08-00436">131</xref>]. Accordingly, patients with bicuspid aortic valve disease had lower eNOS protein expression in aortic endothelial cells compared with tricuspid aortic valves patient specimens [<xref ref-type="bibr" rid="B133-antioxidants-08-00436">133</xref>]. eNOS-derived NO regulates cell growth and protects early cardiac progenitors against apoptosis [<xref ref-type="bibr" rid="B125-antioxidants-08-00436">125</xref>]. This is accomplished through S-nitrosylation and inactivation of caspase-3 [<xref ref-type="bibr" rid="B134-antioxidants-08-00436">134</xref>]. Additionally, shear stress-induced NO production and up-regulation of superoxide dismutase reduce the incidence of endothelial cell death via inhibiting caspase-3 activity [<xref ref-type="bibr" rid="B135-antioxidants-08-00436">135</xref>]. eNOS is also required for cardiomyocyte proliferation, as well as VEGF expression to form the capillary network supplying the muscle [<xref ref-type="bibr" rid="B136-antioxidants-08-00436">136</xref>]. In fact, eNOS intimately controls coronary artery development in mice, as loss of this enzyme results in coronary artery hypoplasia and spontaneous postnatal myocardial infarction [<xref ref-type="bibr" rid="B137-antioxidants-08-00436">137</xref>]. Key transcription factors that control epithelial-to-mesenchymal transition (EMT) and vasculogenesis are downregulated in this model, including <italic>Gata4, Wt1, VEGF, bFGF</italic>, and erythropoietin, all of which are rescued by eNOS overexpression, restoring normal vasculature [<xref ref-type="bibr" rid="B137-antioxidants-08-00436">137</xref>]. Overall, eNOS and NO are critical for the morphogenesis of all major components of the developing heart, and research characterizing their functions has been previously summarized by our group in a more extensive review [<xref ref-type="bibr" rid="B102-antioxidants-08-00436">102</xref>].</p>
</sec>
</sec>
<sec id="sec5-antioxidants-08-00436">
<title>5. Oxidative Stress and Diabetes</title>
<sec id="sec5dot1-antioxidants-08-00436">
<title>5.1. The Anatomy of Reactive Oxygen Species</title>
<p>ROS can exist as neutral molecules, ions, or radicals, such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), the superoxide anion (O<sub>2</sub><sup>•−</sup>), or the hydroxyl radical (<sup>•</sup>OH), respectively [<xref ref-type="bibr" rid="B138-antioxidants-08-00436">138</xref>]. They are produced in subcellular compartments and microdomains as part of cellular metabolic activity. Their biological effects, physiological or pathological, depend on their spatiotemporal characteristics, including the local levels, duration of their release, and interactions between ROS in different subcellular compartments [<xref ref-type="bibr" rid="B138-antioxidants-08-00436">138</xref>,<xref ref-type="bibr" rid="B139-antioxidants-08-00436">139</xref>]. Superoxide is considered a primary ROS and can either be generated from a metabolic process or by activation of oxygen by irradiation. Superoxide cannot readily cross plasma membranes, therefore having local, transient effects. The superoxide anion can react with nitric oxide, forming the highly reactive peroxynitrite [<xref ref-type="bibr" rid="B140-antioxidants-08-00436">140</xref>]. This anion can also be dismutated into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) by superoxide dismutase (SOD). Notably, H<sub>2</sub>O<sub>2</sub> is diffusible across membranes via peroxiporins, a type of aquaporin, to achieve its biological effects in different subcellular compartments [<xref ref-type="bibr" rid="B141-antioxidants-08-00436">141</xref>,<xref ref-type="bibr" rid="B142-antioxidants-08-00436">142</xref>]. While basal physiological level of H<sub>2</sub>O<sub>2</sub> is required for redox signaling, excess production of H<sub>2</sub>O<sub>2</sub> in the cell is detrimental as it can easily be converted into hydroxyl radical <sup>•</sup>OH [<xref ref-type="bibr" rid="B143-antioxidants-08-00436">143</xref>,<xref ref-type="bibr" rid="B144-antioxidants-08-00436">144</xref>]. H<sub>2</sub>O<sub>2</sub> also serves as an endothelium-derived hyperpolarizing factor (EDHF), mediates flow-induced dilation in human coronary arterioles, and contributes to the maintenance of vascular homeostasis, along with other vasodilating factors such as prostacyclin, and NO [<xref ref-type="bibr" rid="B145-antioxidants-08-00436">145</xref>]. In the endothelium, H<sub>2</sub>O<sub>2</sub> is produced from dismutation of superoxide anion generated from several sources including mitochondrial electron transport chain, NADPH oxidase, xanthine oxidase, and importantly eNOS. Thus, eNOS in the endothelium produces not only NO (more pronounced in large conduit vessels), but also H<sub>2</sub>O<sub>2</sub> (predominantly in resistance arteries) to regulate vascular function [<xref ref-type="bibr" rid="B145-antioxidants-08-00436">145</xref>].</p>
<p>Closely linked with the generation of free radicals are redox-active metals. An iron redox couple is associated with the redox state of the cell, and is kept under strict physiological control. In conditions of excessive stress, and excess O<sub>2</sub><sup>•−</sup> release, free iron released from enzymes takes part in Fenton’s reaction and generates secondary ROS, hydroxyl radicals (<xref ref-type="fig" rid="antioxidants-08-00436-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B146-antioxidants-08-00436">146</xref>]. Elevated concentrations of ROS can react with proteins, lipids, carbohydrates, and nucleic acids causing nonspecific damage and permanent functional changes. Hydroxyl radicals produced in close proximity to DNA or RNA can react, resulting in mutations or modifications [<xref ref-type="bibr" rid="B147-antioxidants-08-00436">147</xref>]. Over 20 different types of RNA base damage have been identified, 8-hydroxyguanosine (8-OHG) being the most prevalent oxidized base (<xref ref-type="fig" rid="antioxidants-08-00436-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B148-antioxidants-08-00436">148</xref>]. The hydroxyl radical reacts with the guanine to form C8-OH adduct radical, as it is highly reactive. Next, 8-OHG is generated from the loss of an electron (e<sup>−</sup>) and proton (H<sup>+</sup>) [<xref ref-type="bibr" rid="B148-antioxidants-08-00436">148</xref>]. The hydroxyl radicals can also react with polyunsaturated fatty acid residues of phospholipids, the main component of the cell membrane, which are highly sensitive to oxidation to result in lipid peroxidation (<xref ref-type="fig" rid="antioxidants-08-00436-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B149-antioxidants-08-00436">149</xref>]. Along with mitochondrial ROS production, intracellular sources of ROS include peroxisomes, lysosomes, and enzymes such as NADPH oxidase, xanthine oxidase, and cytochrome p450 [<xref ref-type="bibr" rid="B138-antioxidants-08-00436">138</xref>].</p>
</sec>
<sec id="sec5dot2-antioxidants-08-00436">
<title>5.2. Oxidative Stress Induced by Hyperglycemia</title>
<p>Maternal health and environmental factors have both short-term and long-term consequences for the offspring [<xref ref-type="bibr" rid="B150-antioxidants-08-00436">150</xref>]. Hyperglycemia in the mother alters the environment in which embryos develop because glucose, among other metabolic molecules, can pass freely through the placental barrier. In this altered fetal environment, oxidative stress can result from multiple pathways (<xref ref-type="fig" rid="antioxidants-08-00436-f003">Figure 3</xref>). Excess glucose can be freely taken up by embryonic heart through glucose transporter 1 (GLUT1), the predominant GLUT transporter in the developing heart [<xref ref-type="bibr" rid="B151-antioxidants-08-00436">151</xref>]. The developing heart is sensitive to changes in glucose availability, and early cardiac progenitors mainly rely on glycolysis for energy production. In fact, GLUT1 expression is upregulated in the embryonic heart in experimental models of maternal diabetes, facilitating the glucose overload [<xref ref-type="bibr" rid="B76-antioxidants-08-00436">76</xref>]. However, as cardiomyocytes terminally differentiate they switch to mitochondrial oxidative metabolism pathways [<xref ref-type="bibr" rid="B152-antioxidants-08-00436">152</xref>], and the insulin-sensitive glucose transporter GLUT4 becomes the predominant form postnatally [<xref ref-type="bibr" rid="B153-antioxidants-08-00436">153</xref>].</p>
<p>High levels of glucose promote glycolysis, and electron carriers such as NADH and FADH<sub>2</sub> are increasingly produced, depleted, and reproduced through cycles of glycolysis and oxidative phosphorylation within the mitochondria (<xref ref-type="fig" rid="antioxidants-08-00436-f003">Figure 3</xref>). These molecules act as electron sources for the mitochondrial electron transport chain, and higher levels of electrons flowing through this chain will lead to increased oxygen consumption and ATP formation [<xref ref-type="bibr" rid="B154-antioxidants-08-00436">154</xref>]. At several points during the oxidative phosphorylation process, electrons can react with oxygen, forming radicals [<xref ref-type="bibr" rid="B140-antioxidants-08-00436">140</xref>]. The end result of high glucose is an overproduction of electron donors and generation of reactive oxygen species (ROS) such as superoxide and hydrogen peroxide [<xref ref-type="bibr" rid="B154-antioxidants-08-00436">154</xref>]. This notion is supported by experiments showing that overexpression of uncoupling protein-1 (UCP-1) abolished the proton electrochemical gradient driving oxidative phosphorylation and prevented hyperglycemia-induced ROS production [<xref ref-type="bibr" rid="B155-antioxidants-08-00436">155</xref>].</p>
<p>Moreover, mitochondrial ROS can stimulate the production of cytosolic ROS through several mechanisms. Hydrogen peroxide can lead to the activation of cellular Src kinase, which promotes NADPH oxidase activity, producing superoxide [<xref ref-type="bibr" rid="B156-antioxidants-08-00436">156</xref>]. These reactive molecules can damage DNA and proteins critical for organogenesis [<xref ref-type="bibr" rid="B157-antioxidants-08-00436">157</xref>]. Usually, under conditions of normal NADH to NAD<sup>+</sup> ratio, the production of ROS is relatively low and is reduced by endogenous antioxidants such as superoxide dismutase (SOD), catalase, and glutathione peroxidase [<xref ref-type="bibr" rid="B158-antioxidants-08-00436">158</xref>,<xref ref-type="bibr" rid="B159-antioxidants-08-00436">159</xref>]. High-glucose environments during development disrupt intracellular redox homeostasis by stimulating ROS production, to exceed levels that can appropriately be managed by endogenous antioxidants. Oxidative stress is also potentiated by attenuated glutathione synthesis in diabetic conditions [<xref ref-type="bibr" rid="B160-antioxidants-08-00436">160</xref>]. Further, increased abundance of glucose and glycolysis intermediates stimulate other metabolic pathways that can lead to cellular damage. For example, the hexosamine pathway produces UDP-N-acetylglucosamine (UDP-GlcNAc) from fructose-6-phosphate [<xref ref-type="bibr" rid="B161-antioxidants-08-00436">161</xref>]. This molecule is involved in <italic>O</italic>-linked N-acetylglucosamine modification of proteins, inhibiting their functional capacity. Furthermore, advanced glycation end-products (AGEs) are produced by the advanced glycation and oxidation of proteins, lipids, and nucleic acids, and are thought to play a role in the development of diabetic complications. AGEs activate RAGE (the receptors for AGEs) signaling and cause carbonyl stress, leading to activation of NF-kB, inflammatory response, ROS production, and endothelial dysfunction [<xref ref-type="bibr" rid="B162-antioxidants-08-00436">162</xref>,<xref ref-type="bibr" rid="B163-antioxidants-08-00436">163</xref>]. Overall, the abundance of ROS and the depletion of antioxidants lead to lipid peroxidation, as well as damage to nucleic acids and proteins [<xref ref-type="bibr" rid="B164-antioxidants-08-00436">164</xref>]. In diabetic pregnancies, eNOS dysfunction and oxidative stress/damage ultimately alters gene expression, cell proliferation, survival, and inhibits EMT, resulting in CHDs in the offspring (<xref ref-type="fig" rid="antioxidants-08-00436-f003">Figure 3</xref>).</p>
</sec>
</sec>
<sec id="sec6-antioxidants-08-00436">
<title>6. Involvement of eNOS Uncoupling and ROS in Pregestational Diabetes-Induced CHDs</title>
<sec id="sec6dot1-antioxidants-08-00436">
<title>6.1. Experimental Models of CHDs Induced by Hyperglycemia and Pregestational Diabetes</title>
<p>Hyperglycemia has been recognized as a teratogen causing embryopathy associated with neural tube defects and CHDs [<xref ref-type="bibr" rid="B165-antioxidants-08-00436">165</xref>,<xref ref-type="bibr" rid="B166-antioxidants-08-00436">166</xref>]. To simulate CHDs in humans due to pregestational diabetes, both ex vivo and in vivo animal models have been employed. Whole embryo culture of rodents allows direct observation of the growth and development of embryos outside the maternal uterus for up to 5 days. Additionally, culture conditions can be easily manipulated, for example using high glucose concentrations to mimic hyperglycemia. Although the rodent whole embryo culture was initially described about 60 years ago, because of these advantages, it is still being used to study organogenesis [<xref ref-type="bibr" rid="B167-antioxidants-08-00436">167</xref>]. Chick embryo culture has also been used to study the effects of hyperglycemia on heart development. Exposure of neural crest cells to high glucose in vivo results in double-outlet right ventricle (DORV) and ventricular septal defect (VSD) [<xref ref-type="bibr" rid="B166-antioxidants-08-00436">166</xref>]. However, the in vivo rodent models induced by either streptozotocin (STZ) with various administration regimens or high-fat diet plus low-dose STZ to simulate type 1 or 2 diabetes, respectively, are the most commonly used and clinically relevant models of maternal diabetes. We have employed a mouse model of pregestational diabetes induced by STZ, which produced a wide spectrum of CHDs in the offspring, including ASD, VSD, atrioventricular septal defect (ASVD), DORV, tetralogy of Fallot, transposition of great arteries (TGA), and hypoplastic left heart syndrome (HLHS) [<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>,<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>,<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>,<xref ref-type="bibr" rid="B18-antioxidants-08-00436">18</xref>]. Some of the fetuses exhibit coronary artery malformations with reduced coronary artery diameter and abundance, resembling hypoplastic coronary artery disease (HCAD) in humans [<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>,<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>]. Studies using these in vivo rodent models to examine the roles of NO and ROS are summarized in <xref ref-type="table" rid="antioxidants-08-00436-t001">Table 1</xref>.</p>
</sec>
<sec id="sec6dot2-antioxidants-08-00436">
<title>6.2. eNOS Uncoupling and CHDs in Pregestational Diabetes</title>
<p>The molecular mechanisms by which hyperglycemia causes CHDs are complex and may involve multiple signaling pathways. Interestingly, eNOS expression and NO levels are reduced in fetal hearts of offspring of diabetic dams [<xref ref-type="bibr" rid="B13-antioxidants-08-00436">13</xref>]. The dysfunctional eNOS induced by high glucose stress is a result of reduced chromatin accessibility at the <italic>Nos3</italic> locus and decreased eNOS phosphorylation of serine 1177 by the protein kinase Akt [<xref ref-type="bibr" rid="B14-antioxidants-08-00436">14</xref>,<xref ref-type="bibr" rid="B174-antioxidants-08-00436">174</xref>]. Furthermore, lower NO levels are associated with higher Jarid2 expression and its enhanced interaction with the <italic>Notch1</italic> locus, leading to decreased Notch1 expression and a higher incidence of VSDs in offspring of maternal diabetes [<xref ref-type="bibr" rid="B14-antioxidants-08-00436">14</xref>]. Notably, pregestational diabetes lowers fetal BH4 levels, and induces eNOS uncoupling, elevated superoxide generation, as well as altered cardiac gene expression of <italic>Gata4</italic>, <italic>Gata5</italic>, <italic>Nkx2.5</italic>, <italic>Tbx5</italic>, and <italic>Bmp10</italic> in the fetal heart [<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>]. Moreover, mRNA levels of GTPCH1 and DHFR, enzymes involved in BH4 synthesis, were also significantly reduced at E12.5 in the fetal heart of offspring from diabetic dams, compared with control [<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>]. To elucidate the role of eNOS uncoupling in the pathogenesis of CHDs, diabetic dams were treated with sapropterin (Kuvan<sup>®</sup>), an orally active synthetic form of BH4. Our results showed that oral sapropterin treatment in the diabetic dams recouples eNOS and lowers ROS levels in fetal hearts. Further, impaired cardiac gene expression and cell proliferation induced by maternal diabetes were normalized with sapropterin treatment. Most strikingly, the incidence of CHDs was lowered from 59% to 27%, and major abnormalities such as AVSD and DORV were absent in the sapropterin-treated group [<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>]. The study shows a pivotal role of eNOS uncoupling in the pathogenesis of CHDs in diabetic pregnancies (<xref ref-type="table" rid="antioxidants-08-00436-t001">Table 1</xref>).</p>
</sec>
<sec id="sec6dot3-antioxidants-08-00436">
<title>6.3. Role of ROS in Pathogenesis of CHDs in Pregestational Diabetes</title>
<p>Elevated ROS levels and oxidative damage have been proposed to contribute to diabetic complications [<xref ref-type="bibr" rid="B165-antioxidants-08-00436">165</xref>,<xref ref-type="bibr" rid="B175-antioxidants-08-00436">175</xref>]. Ex vivo cultures of rat embryos under high-glucose conditions show glutathione depletion, excessive ROS production, growth retardation, and severe malformations after exposure to high glucose [<xref ref-type="bibr" rid="B176-antioxidants-08-00436">176</xref>,<xref ref-type="bibr" rid="B177-antioxidants-08-00436">177</xref>]. In a U-substrain of Sprague-Dawley rats at Uppsala University, Sweden, pregestational diabetes induced by STZ resulted in craniofacial and skeletal malformations in the offspring [<xref ref-type="bibr" rid="B165-antioxidants-08-00436">165</xref>]. Additionally, the rat offspring of maternal diabetes also show a variety of CHDs including DORV, persistent truncus arteriosus, VSD, teratology of Fallot, and pharyngeal arch artery defects [<xref ref-type="bibr" rid="B19-antioxidants-08-00436">19</xref>,<xref ref-type="bibr" rid="B168-antioxidants-08-00436">168</xref>]. Furthermore, maternal treatment with antioxidants such as butylated hydroxytoluene and vitamin C and E reduced the rate of craniofacial and skeletal malformations, while treatment with vitamin E decreased the rate and severity of CHDs in rats, suggesting the involvement of ROS [<xref ref-type="bibr" rid="B19-antioxidants-08-00436">19</xref>,<xref ref-type="bibr" rid="B178-antioxidants-08-00436">178</xref>,<xref ref-type="bibr" rid="B179-antioxidants-08-00436">179</xref>,<xref ref-type="bibr" rid="B180-antioxidants-08-00436">180</xref>]. Microarray analysis shows that genes involved in apoptosis, proliferation, migration, and differentiation in fetal hearts at E13.5 and E15.5 are differentially expressed in embryos of diabetic pregnancy [<xref ref-type="bibr" rid="B169-antioxidants-08-00436">169</xref>]. These changes in gene expression and downregulation of Pax3 are associated with cardiac malformation such as persistent truncus arteriosus and VSD [<xref ref-type="bibr" rid="B170-antioxidants-08-00436">170</xref>]. Using reporter mice linked to Pax3 expression, defective cardiac neural crest cell migration and outflow tract defects were found in embryos of maternal diabetes/hyperglycemia, and reduced by antioxidant treatment with glutathione ethyl ester or vitamin E [<xref ref-type="bibr" rid="B20-antioxidants-08-00436">20</xref>].</p>
<p>Subsequent studies from us and others demonstrated that both ROS and oxidative stress are elevated in the fetal heart of maternal diabetes. Notably, inhibition of ROS using oral treatment of antioxidant N-acetylcysteine or by transgenic overexpression of superoxide dismutase 1 (SOD1) lowers fetal heart ROS levels and reduces the incidence of CHDs and coronary artery malformations induced by pregestational diabetes [<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>,<xref ref-type="bibr" rid="B18-antioxidants-08-00436">18</xref>,<xref ref-type="bibr" rid="B21-antioxidants-08-00436">21</xref>,<xref ref-type="bibr" rid="B22-antioxidants-08-00436">22</xref>]. Interestingly, intravenous administration of miRNA-containing exosomes isolated from diabetic dams to control dams at E8.5 or E11.5 is sufficient to induce VSDs in fetuses [<xref ref-type="bibr" rid="B171-antioxidants-08-00436">171</xref>]. Further, expression of genes and miRNAs critical to heart morphogenesis is regulated by ROS in the fetal heart of maternal diabetes since the changes were normalized by N-acetylcysteine treatment or overexpression of SOD1 [<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>,<xref ref-type="bibr" rid="B18-antioxidants-08-00436">18</xref>,<xref ref-type="bibr" rid="B23-antioxidants-08-00436">23</xref>]. Additionally, cell apoptosis and endoplasmic reticulum (ER) stress are involved in CHD pathogenesis in maternal diabetes as deficiency of apoptosis signal-regulating kinase 1 (ASK1) lowers apoptosis, ER stress, and incidence of CHDs in offspring of pregestational diabetes [<xref ref-type="bibr" rid="B24-antioxidants-08-00436">24</xref>]. Together, these studies support a critical role of ROS in the pathogenesis of CHDs in pregestational diabetes in rodents (<xref ref-type="table" rid="antioxidants-08-00436-t001">Table 1</xref>).</p>
<p>It should be noted that maternal supplementation with antioxidants vitamin E and C during pregnancy in general population shows no overall benefit or harm for the prevention of stillbirth, neonatal death, poor fetal growth, preterm birth, or pre-eclampsia [<xref ref-type="bibr" rid="B181-antioxidants-08-00436">181</xref>,<xref ref-type="bibr" rid="B182-antioxidants-08-00436">182</xref>]. In fact, some studies show that high maternal vitamin E intake by diet or supplements even increases the risk of CHDs in children [<xref ref-type="bibr" rid="B183-antioxidants-08-00436">183</xref>]. These results are consistent with a recent meta-analysis showing no effect of vitamin E and C supplementation on the cardiovascular outcomes including myocardial infarction, stroke, total death, and cardiac death in adults [<xref ref-type="bibr" rid="B184-antioxidants-08-00436">184</xref>]. The failure to translate preclinical paradigms into clinical settings underscores our limited knowledge on ROS biology, particularly the subcellular compartmentation of ROS sources and antioxidant systems, which may dictate their final effect. However, whether N-acetylcysteine or BH4 affects the incidence of CHDs of children in pregestational diabetes patients remains to be investigated.</p>
<p>Additionally, AGEs represent another mechanism implicated in hyperglycemia-induced malformations. Specifically in the rat embryo, 3-deoxyglucasone, a precursor in the formation of AGEs was demonstrated to be increased in high-glucose compared with low-glucose conditions. The increased level of 3-deoxyglucasone was associated with an increased rate of embryonic malformations [<xref ref-type="bibr" rid="B185-antioxidants-08-00436">185</xref>]. Furthermore, maternal diabetes in rats increased the accumulation of AGEs such as Nε(carboxymethyl)lysine (CML) in areas susceptible to diabetes-induced CHDs, including the outflow tract of the heart and the aortic arch [<xref ref-type="bibr" rid="B186-antioxidants-08-00436">186</xref>]. These studies suggest that AGEs are associated with congenital malformations, although their definitive role in the pathogenesis of CHDs remains to be determined.</p>
</sec>
</sec>
<sec id="sec7-antioxidants-08-00436">
<title>7. Maternal Exercise Reduces Incidence of CHDs from Pregestational Diabetes</title>
<p>Clinical studies suggest an overall healthy lifestyle with regular exercise before and during pregnancy is important to ensure a healthy outcome of the newborns [<xref ref-type="bibr" rid="B187-antioxidants-08-00436">187</xref>]. Exercise has a number of benefits including, but not limited to, improvements of metabolism, cardiovascular health, cognition, fertility, bone health, immune response, and even slowing down aging [<xref ref-type="bibr" rid="B188-antioxidants-08-00436">188</xref>]. Exercise during gestation lowers the risk of gestational diabetes mellitus and improves offspring health [<xref ref-type="bibr" rid="B189-antioxidants-08-00436">189</xref>]. A joint Society of Obstetricians and Gynaecologists of Canada (SOGC)/Canadian Society for Exercise Physiology (CSEP) clinical practice guideline recommends 150 min of moderate-intensity exercise per week during pregnancy to achieve clinically meaningful health benefits and reductions in pregnancy complications [<xref ref-type="bibr" rid="B190-antioxidants-08-00436">190</xref>]. Remarkably, maternal voluntary exercise for 3 months before conception has recently been shown to lower the incidence of VSDs in offspring of old mothers, suggesting maternal exercise reduces the risk of CHDs associated with maternal age [<xref ref-type="bibr" rid="B191-antioxidants-08-00436">191</xref>]. Using a STZ diabetes mouse model, we examined the effects of maternal exercise on pathogenesis of CHDs induced by pregestational diabetes [<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>]. Our results show that maternal exercise reduces ROS levels and oxidative stress and improves eNOS phosphorylation in the fetal hearts of offspring from mice with diabetes. Most notably, maternal exercise lowered the incidence of CHDs and coronary artery malformation by 58% [<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>]. Few other studies have examined changes in heart development associated with maternal exercise. There is evidence that exercise during pregnancy may influence the maturation of cardiac autonomic control and increase right ventricular cardiac output in children [<xref ref-type="bibr" rid="B192-antioxidants-08-00436">192</xref>,<xref ref-type="bibr" rid="B193-antioxidants-08-00436">193</xref>], and improve NO bioavailability and vascular function in the fetus of pigs [<xref ref-type="bibr" rid="B194-antioxidants-08-00436">194</xref>].</p>
<p>Although several exercise-mediated adaptations have been identified that may play a role in modulating cardioprotective response, the mechanism by which maternal exercise alters fetal heart development remains unclear. Exercise has been demonstrated to influence gene expression and activate pathways that alter angiogenesis, proliferation, and cellular metabolism [<xref ref-type="bibr" rid="B188-antioxidants-08-00436">188</xref>]. Peroxisome proliferator-activated receptors-gamma (PPARγ) coactivator-1a (PGC-1α) is a master regulator of energy metabolism. In the heart, PGC-1α is the major coactivator for transcription factors PPARα and PPARγ, which regulate cardiac metabolism [<xref ref-type="bibr" rid="B195-antioxidants-08-00436">195</xref>]. The PPARβ/δ isoform has been demonstrated to protect cardiomyocytes against apoptosis induced by oxidative stress, and is known to be induced by exercise in skeletal muscle [<xref ref-type="bibr" rid="B196-antioxidants-08-00436">196</xref>]. Through activation of other transcription factors, PGC-1α also stimulates mitochondrial biogenesis and promotes the expression of electron transport chain proteins. PGC-1α is upregulated with exercise and has been shown to regulate mitochondrial antioxidant defense in vascular endothelial cells [<xref ref-type="bibr" rid="B196-antioxidants-08-00436">196</xref>]. Laker et al. found that maternal exercise modified the methylation status of the PGC-1α promoter and increased its gene expression in the offspring [<xref ref-type="bibr" rid="B197-antioxidants-08-00436">197</xref>]. In future studies, it would be worthwhile to evaluate the involvement of PGC-1α in mediating the effects observed in our model of pregestational diabetes.</p>
<p>In adults, exercise elevates ROS production, which paradoxically leads to improved redox capacity through upregulation of antioxidant enzymes in cardiac and skeletal muscle [<xref ref-type="bibr" rid="B198-antioxidants-08-00436">198</xref>,<xref ref-type="bibr" rid="B199-antioxidants-08-00436">199</xref>]. In fact, exercise-induced resistance to ischemia-reperfusion injury is mediated by such adaptations to antioxidant defenses [<xref ref-type="bibr" rid="B200-antioxidants-08-00436">200</xref>]. Promotion of NO signaling through exercise is also known to contribute to this protective mechanism [<xref ref-type="bibr" rid="B201-antioxidants-08-00436">201</xref>]. During exercise, the β<sub>3</sub>-adrenergic receptor is stimulated, and its activation increases eNOS activity and NO bioavailability [<xref ref-type="bibr" rid="B202-antioxidants-08-00436">202</xref>]. Activation and phosphorylation of eNOS-Ser1177 in the heart is mediated by Akt activation. As Akt activation has been shown to promote cardiomyocyte proliferation and expansion of cardiac progenitors [<xref ref-type="bibr" rid="B203-antioxidants-08-00436">203</xref>], this pathway may also have contributed to protection against CHD pathogenesis observed in our model [<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>]. As of now, fetal adaptations in response to maternal exercise has not been well characterized. Our results suggest that maternal exercise may improve the capacity to maintain redox balance in the fetal heart. Results from recent studies support this notion, showing that maternal exercise resulted in increased eNOS and extracellular SOD expression in vascular smooth muscle cells, increased mitochondrial enzymatic activity, and decreased ROS in fetal cardiovascular tissues [<xref ref-type="bibr" rid="B204-antioxidants-08-00436">204</xref>,<xref ref-type="bibr" rid="B205-antioxidants-08-00436">205</xref>].</p>
<p>All in all, maternal exercise may protect against abnormal heart development through multiple mechanisms. For example, exercise has been shown to decrease the expression of transcription factor C/EBPβ in the heart, leading to the upregulation of cardiac factors <italic>Gata4</italic>, <italic>Tbx5</italic>, and <italic>Nkx2.5</italic> to promote cell proliferation, differentiation, and physiological hypertrophy in adults [<xref ref-type="bibr" rid="B206-antioxidants-08-00436">206</xref>]. There is also emerging interest in epigenetic regulation of gene expression and micro-RNAs (miRNA) involved in heart development. Specifically, miR-1/miR-133 clusters in the heart are regulated by myocyte-enhancer factor 2 (Mef2) and Nkx2.5 and are involved in regulation of cell proliferation, apoptosis, and differentiation during heart development. Some of these miRNAs are upregulated with exercise [<xref ref-type="bibr" rid="B207-antioxidants-08-00436">207</xref>]. The exact role of eNOS and ROS signaling in the exercise-induced benefits remains to be determined, and there are many exciting directions for possible future studies.</p>
</sec>
<sec id="sec8-antioxidants-08-00436">
<title>8. Conclusions</title>
<p>It is clear that the diabetes epidemic poses a major threat to both high- and low-income countries alike, given the alarming rate at which prevalence is rising globally [<xref ref-type="bibr" rid="B54-antioxidants-08-00436">54</xref>]. CHDs are an important consequence of pregestational diabetes, causing significant morbidity, mortality, and burden on healthcare costs. The teratogenic potential of maternal hyperglycemia has been well documented for generations, and research thus far has uncovered perturbations to ROS and NO homeostasis to be major drivers of this phenomenon. Cardiogenesis is a highly complex process governed by a multitude of factors that are sensitive to oxidative damage, including eNOS, the enzyme that produces NO. Unfortunately, clinical evidence suggests that insulin treatment and glycemic control alone does not completely eliminate the risk of CHDs in the children of women with pregestational diabetes. Animal studies have identified several antioxidants to significantly protect against CHDs induced by maternal diabetes. Factors such as BH4, which bridges the homeostasis of both ROS and NO, show promise to be potential treatment in the prevention of CHDs during maternal diabetes. Additionally, lifestyle modifications such as maternal exercise, which reduces ROS and increases eNOS activity, may be a simple yet effective intervention to supplement pharmacological therapy and minimize risks of birth defects in mothers with diabetes. In conclusion, although great strides have been made in understanding the pathogenesis of CHDs, a significant paucity in human data exists, limiting the advancement of clinical treatment. Moving forward, further translational research is needed in order to evaluate the efficacy of such interventions in human populations.</p>
</sec>
</body>
<back>
<notes>
<title>Author Contributions</title>
<p>A.E., T.S. and E.R.G. drafted the manuscript. Q.F. revised the manuscript. All authors proofread the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>Work in the authors’ laboratory was supported by grants from the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Canada (HSFC), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Richard and Jean Ivey Fund. QF is a Richard and Jean Ivey Chair in Molecular Toxicology, Schulich School of Medicine and Dentistry, Western University.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-antioxidants-08-00436">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierpont</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Basson</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>D.W.J.</given-names>
</name>
<name>
<surname>Gelb</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Giglia</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Goldmuntz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sable</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics</article-title>
<source/>Circulation
          <year>2007</year>
<volume>115</volume>
<fpage>3015</fpage>
<lpage>3038</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.183056</pub-id>
<pub-id pub-id-type="pmid">17519398</pub-id>
</element-citation>
</ref>
<ref id="B2-antioxidants-08-00436">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilboa</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Kucik</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Oster</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Riehle-Colarusso</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nembhard</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marelli</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Congenital heart defects in the United States: Estimating the magnitude of the affected population in 2010</article-title>
<source/>Circulation
          <year>2016</year>
<volume>134</volume>
<fpage>101</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.019307</pub-id>
<pub-id pub-id-type="pmid">27382105</pub-id>
</element-citation>
</ref>
<ref id="B3-antioxidants-08-00436">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjamin</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Virani</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Callaway</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Chamberlain</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chiuve</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Cushman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Delling</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Deo</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heart disease and stroke statistics-2018 update: A report from the American Heart Association</article-title>
<source/>Circulation
          <year>2018</year>
<volume>137</volume>
<fpage>e67</fpage>
<lpage>e492</lpage>
<pub-id pub-id-type="doi">10.1161/CIR.0000000000000558</pub-id>
<pub-id pub-id-type="pmid">29386200</pub-id>
</element-citation>
</ref>
<ref id="B4-antioxidants-08-00436">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleves</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Ghaffar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mosley</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>First-year survival of infants born with congenital heart defects in Arkansas (1993–1998): A survival analysis using registry data</article-title>
<source/>Birth Defects Res. A
          <year>2003</year>
<volume>67</volume>
<fpage>662</fpage>
<lpage>668</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.10119</pub-id>
<pub-id pub-id-type="pmid">14703791</pub-id>
</element-citation>
</ref>
<ref id="B5-antioxidants-08-00436">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oyen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Leirgul</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Priest</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mathiesen</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Quertermous</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wohlfahrt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Melbye</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Prepregnancy diabetes and offspring risk of congenital heart disease: A nationwide cohort study</article-title>
<source/>Circulation
          <year>2016</year>
<volume>133</volume>
<fpage>2243</fpage>
<lpage>2253</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.017465</pub-id>
<pub-id pub-id-type="pmid">27166384</pub-id>
</element-citation>
</ref>
<ref id="B6-antioxidants-08-00436">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Lisonkova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van den Hof</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sauve</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.S.</given-names>
</name>
<collab>Canadian Perinatal Surveillance System (Public Health Agency of Canada)</collab>
</person-group>
<article-title>Association between maternal chronic conditions and congenital heart defects: A population-based cohort study</article-title>
<source/>Circulation
          <year>2013</year>
<volume>128</volume>
<fpage>583</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001054</pub-id>
<pub-id pub-id-type="pmid">23812182</pub-id>
</element-citation>
</ref>
<ref id="B7-antioxidants-08-00436">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casson</surname>
<given-names>I.F.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>McKendrick</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Pennycook</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pharoah</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Platt</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Stanisstreet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Velszen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Walkinshaw</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study</article-title>
<source/>BMJ
          <year>1997</year>
<volume>315</volume>
<fpage>275</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.315.7103.275</pub-id>
<pub-id pub-id-type="pmid">9274545</pub-id>
</element-citation>
</ref>
<ref id="B8-antioxidants-08-00436">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loffredo</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Epidemiology of cardiovascular malformations: Prevalence and risk factors</article-title>
<source/>Am. J. Med. Genet.
          <year>2000</year>
<volume>97</volume>
<fpage>319</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(200024)97:4&lt;319::AID-AJMG1283&gt;3.0.CO;2-E</pub-id>
<pub-id pub-id-type="pmid">11376444</pub-id>
</element-citation>
</ref>
<ref id="B9-antioxidants-08-00436">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>LoBue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Diabetes prevention: Reproductive age women affected by insulin resistance</article-title>
<source/>Womens Health
          <year>2016</year>
<volume>12</volume>
<fpage>427</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1177/1745505716653691</pub-id>
</element-citation>
</ref>
<ref id="B10-antioxidants-08-00436">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mansford</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Opie</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan</article-title>
<source/>Lancet
          <year>1968</year>
<volume>1</volume>
<fpage>670</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(68)92103-X</pub-id>
<pub-id pub-id-type="pmid">4170654</pub-id>
</element-citation>
</ref>
<ref id="B11-antioxidants-08-00436">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Janecek</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kittredge</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hering</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>The streptozotocin-induced diabetic nude mouse model: Differences between animals from different sources</article-title>
<source/>Comp. Med.
          <year>2011</year>
<volume>61</volume>
<fpage>356</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">22330251</pub-id>
</element-citation>
</ref>
<ref id="B12-antioxidants-08-00436">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szkudelski</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas</article-title>
<source/>Physiol. Res.
          <year>2001</year>
<volume>50</volume>
<fpage>537</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">11829314</pub-id>
</element-citation>
</ref>
<ref id="B13-antioxidants-08-00436">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Dheen</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Bay</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice</article-title>
<source/>Exp. Biol. Med.
          <year>2008</year>
<volume>233</volume>
<fpage>1421</fpage>
<lpage>1432</lpage>
<pub-id pub-id-type="doi">10.3181/0806-RM-186</pub-id>
<pub-id pub-id-type="pmid">18824721</pub-id>
</element-citation>
</ref>
<ref id="B14-antioxidants-08-00436">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>LaHaye</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Majumdar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease</article-title>
<source/>JCI Insight
          <year>2017</year>
<volume>2</volume>
<fpage>e95085</fpage>
<pub-id pub-id-type="doi">10.1172/jci.insight.95085</pub-id>
<pub-id pub-id-type="pmid">29046480</pub-id>
</element-citation>
</ref>
<ref id="B15-antioxidants-08-00436">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engineer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saiyin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kucey</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Urquhart</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Drysdale</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Norozi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Sapropterin treatment prevents congenital heart defects induced by pregestational diabetes mellitus in mice</article-title>
<source/>J. Am. Heart Assoc.
          <year>2018</year>
<volume>7</volume>
<fpage>e009624</fpage>
<pub-id pub-id-type="doi">10.1161/JAHA.118.009624</pub-id>
<pub-id pub-id-type="pmid">30608180</pub-id>
</element-citation>
</ref>
<ref id="B16-antioxidants-08-00436">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saiyin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Engineer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Maternal voluntary exercise mitigates oxidative stress and incidence of congenital heart defects in pre-gestational diabetes</article-title>
<source/>J. Cell. Mol. Med.
          <year>2019</year>
<volume>23</volume>
<fpage>5553</fpage>
<lpage>5565</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.14439</pub-id>
<pub-id pub-id-type="pmid">31211496</pub-id>
</element-citation>
</ref>
<ref id="B17-antioxidants-08-00436">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moazzen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Pregestational diabetes induces fetal coronary artery malformation via reactive oxygen species signaling</article-title>
<source/>Diabetes
          <year>2015</year>
<volume>64</volume>
<fpage>1431</fpage>
<lpage>1443</lpage>
<pub-id pub-id-type="doi">10.2337/db14-0190</pub-id>
<pub-id pub-id-type="pmid">25422104</pub-id>
</element-citation>
</ref>
<ref id="B18-antioxidants-08-00436">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moazzen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Velenosi</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Urquhart</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Wisse</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Gittenberger-de Groot</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes</article-title>
<source/>Cardiovasc. Diabetol.
          <year>2014</year>
<volume>13</volume>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/1475-2840-13-46</pub-id>
<pub-id pub-id-type="pmid">24533448</pub-id>
</element-citation>
</ref>
<ref id="B19-antioxidants-08-00436">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siman</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Gittenberger-De Groot</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Wisse</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
</person-group>
<article-title>Malformations in offspring of diabetic rats: Morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment</article-title>
<source/>Teratology
          <year>2000</year>
<volume>61</volume>
<fpage>355</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9926(200005)61:5&lt;355::AID-TERA7&gt;3.0.CO;2-W</pub-id>
<pub-id pub-id-type="pmid">10777831</pub-id>
</element-citation>
</ref>
<ref id="B20-antioxidants-08-00436">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Relaix</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sandell</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Loeken</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects</article-title>
<source/>Birth Defects Res. A
          <year>2008</year>
<volume>82</volume>
<fpage>453</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20457</pub-id>
</element-citation>
</ref>
<ref id="B21-antioxidants-08-00436">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Superoxide dismutase 1 in vivo ameliorates maternal diabetes mellitus-induced apoptosis and heart defects through restoration of impaired Wnt signaling</article-title>
<source/>Circ. Cardiovasc. Genet.
          <year>2015</year>
<volume>8</volume>
<fpage>665</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCGENETICS.115.001138</pub-id>
<pub-id pub-id-type="pmid">26232087</pub-id>
</element-citation>
</ref>
<ref id="B22-antioxidants-08-00436">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reece</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2015</year>
<volume>212</volume>
<fpage>650</fpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2015.01.014</pub-id>
<pub-id pub-id-type="pmid">25595579</pub-id>
</element-citation>
</ref>
<ref id="B23-antioxidants-08-00436">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Reece</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Harman</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>microRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice</article-title>
<source/>Reprod. Toxicol.
          <year>2016</year>
<volume>65</volume>
<fpage>365</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2016.09.007</pub-id>
<pub-id pub-id-type="pmid">27629361</pub-id>
</element-citation>
</ref>
<ref id="B24-antioxidants-08-00436">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Quon</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>ASK1 mediates the teratogenicity of diabetes in the developing heart by inducing ER stress and inhibiting critical factors essential for cardiac development</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2015</year>
<volume>309</volume>
<fpage>E487</fpage>
<lpage>E499</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00121.2015</pub-id>
<pub-id pub-id-type="pmid">26173459</pub-id>
</element-citation>
</ref>
<ref id="B25-antioxidants-08-00436">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mdaki</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Wachal</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Schimelpfenig</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Dooyema</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Louwagie</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Baack</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Maternal high-fat diet impairs cardiac function in offspring of diabetic pregnancy through metabolic stress and mitochondrial dysfunction</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2016</year>
<volume>310</volume>
<fpage>H681</fpage>
<lpage>H692</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00795.2015</pub-id>
<pub-id pub-id-type="pmid">26801311</pub-id>
</element-citation>
</ref>
<ref id="B26-antioxidants-08-00436">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marelli</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Ionescu-Ittu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dendukuri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kaouache</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010</article-title>
<source/>Circulation
          <year>2014</year>
<volume>130</volume>
<fpage>749</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.008396</pub-id>
<pub-id pub-id-type="pmid">24944314</pub-id>
</element-citation>
</ref>
<ref id="B27-antioxidants-08-00436">
<label>27.</label>
<element-citation publication-type="web">
<article-title>Canadian Congenital Heart Alliance</article-title>
<year>2016</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cchaforlife.org/facts-issues">https://www.cchaforlife.org/facts-issues</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-07-20">(accessed on 20 July 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B28-antioxidants-08-00436">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The incidence of congenital heart disease</article-title>
<source/>J. Am. Coll. Cardiol.
          <year>2002</year>
<volume>39</volume>
<fpage>1890</fpage>
<lpage>1900</lpage>
<pub-id pub-id-type="doi">10.1016/S0735-1097(02)01886-7</pub-id>
<pub-id pub-id-type="pmid">12084585</pub-id>
</element-citation>
</ref>
<ref id="B29-antioxidants-08-00436">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leirgul</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fomina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brodwall</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Greve</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Holmstrom</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vollset</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Tell</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Oyen</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Birth prevalence of congenital heart defects in Norway 1994–2009—A nationwide study</article-title>
<source/>Am. Heart J.
          <year>2014</year>
<volume>168</volume>
<fpage>956</fpage>
<lpage>964</lpage>
<pub-id pub-id-type="doi">10.1016/j.ahj.2014.07.030</pub-id>
<pub-id pub-id-type="pmid">25458661</pub-id>
</element-citation>
</ref>
<ref id="B30-antioxidants-08-00436">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatt</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kuehl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alpert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brabeck</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Crumb</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>W.R.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Earing</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Ghoshhajra</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Karamlou</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital Heart disease in the older adult: A scientific statement from the American Heart Association</article-title>
<source/>Circulation
          <year>2015</year>
<volume>131</volume>
<fpage>1884</fpage>
<lpage>1931</lpage>
<pub-id pub-id-type="doi">10.1161/CIR.0000000000000204</pub-id>
<pub-id pub-id-type="pmid">25896865</pub-id>
</element-citation>
</ref>
<ref id="B31-antioxidants-08-00436">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ciuffreda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quattrociocchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Preda</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The grown-up congenital cardiac patient</article-title>
<source/>J. Cardiovasc. Med.
          <year>2007</year>
<volume>8</volume>
<fpage>78</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.2459/01.JCM.0000247441.79644.4b</pub-id>
</element-citation>
</ref>
<ref id="B32-antioxidants-08-00436">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warnes</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>The adult with congenital heart disease: Born to be bad?</article-title>
<source/>J. Am. Coll. Cardiol.
          <year>2005</year>
<volume>46</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2005.02.083</pub-id>
</element-citation>
</ref>
<ref id="B33-antioxidants-08-00436">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Jefferson</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Newburger</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Brain in congenital heart disease across the lifespan: The cumulative burden of injury</article-title>
<source/>Circulation
          <year>2016</year>
<volume>133</volume>
<fpage>1951</fpage>
<lpage>1962</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.019881</pub-id>
<pub-id pub-id-type="pmid">27185022</pub-id>
</element-citation>
</ref>
<ref id="B34-antioxidants-08-00436">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egbe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Uppu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Prevalence of congenital anomalies in newborns with congenital heart disease diagnosis</article-title>
<source/>Ann. Pediatr. Cardiol.
          <year>2014</year>
<volume>7</volume>
<fpage>86</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.4103/0974-2069.132474</pub-id>
<pub-id pub-id-type="pmid">24987252</pub-id>
</element-citation>
</ref>
<ref id="B35-antioxidants-08-00436">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calderon</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Executive function in patients with congenital heart disease: Only the tip of the iceberg?</article-title>
<source/>J. Pediatr.
          <year>2016</year>
<volume>173</volume>
<fpage>7</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2016.02.066</pub-id>
<pub-id pub-id-type="pmid">26995698</pub-id>
</element-citation>
</ref>
<ref id="B36-antioxidants-08-00436">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marino</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Lipkin</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Newburger</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Peacock</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gerdes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Mussatto</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Uzark</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>W.H.</given-names>
<suffix>Jr.</suffix>
</name>
<etal></etal>
</person-group>
<article-title>Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management: A scientific statement from the American Heart Association</article-title>
<source/>Circulation
          <year>2012</year>
<volume>126</volume>
<fpage>1143</fpage>
<lpage>1172</lpage>
<pub-id pub-id-type="doi">10.1161/CIR.0b013e318265ee8a</pub-id>
<pub-id pub-id-type="pmid">22851541</pub-id>
</element-citation>
</ref>
<ref id="B37-antioxidants-08-00436">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arth</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Tinker</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Simeone</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Ailes</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Cragan</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Grosse</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Inpatient hospitalization costs associated with birth defects among persons of all ages—United States, 2013</article-title>
<source/>Morb. Mortal. Wkly. Rep.
          <year>2017</year>
<volume>66</volume>
<fpage>41</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.15585/mmwr.mm6602a1</pub-id>
<pub-id pub-id-type="pmid">28103210</pub-id>
</element-citation>
</ref>
<ref id="B38-antioxidants-08-00436">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Bom</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zomer</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Zwinderman</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Meijboom</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Bouma</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>The changing epidemiology of congenital heart disease</article-title>
<source/>Nat. Rev. Cardiol.
          <year>2011</year>
<volume>8</volume>
<fpage>50</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nrcardio.2010.166</pub-id>
<pub-id pub-id-type="pmid">21045784</pub-id>
</element-citation>
</ref>
<ref id="B39-antioxidants-08-00436">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McElhinney</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Blinder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Goldmuntz</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>NKX2.5 mutations in patients with congenital heart disease</article-title>
<source/>J. Am. Coll. Cardiol.
          <year>2003</year>
<volume>42</volume>
<fpage>1650</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2003.05.004</pub-id>
<pub-id pub-id-type="pmid">14607454</pub-id>
</element-citation>
</ref>
<ref id="B40-antioxidants-08-00436">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paladini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tartaglione</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Agangi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Teodoro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forleo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Borghese</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The association between congenital heart disease and Down syndrome in prenatal life</article-title>
<source/>Ultrasound Obstet. Gynecol.
          <year>2000</year>
<volume>15</volume>
<fpage>104</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1046/j.1469-0705.2000.00027.x</pub-id>
<pub-id pub-id-type="pmid">10775990</pub-id>
</element-citation>
</ref>
<ref id="B41-antioxidants-08-00436">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Lupo</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: A systematic review and metaanalysis</article-title>
<source/>Pediatr. Cardiol.
          <year>2013</year>
<volume>34</volume>
<fpage>398</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1007/s00246-012-0470-x</pub-id>
<pub-id pub-id-type="pmid">22886364</pub-id>
</element-citation>
</ref>
<ref id="B42-antioxidants-08-00436">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Dervan</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Reiger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buddhe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Risk of congenital heart defects in the offspring of smoking mothers: A population-based study</article-title>
<source/>J. Pediatr.
          <year>2015</year>
<volume>166</volume>
<fpage>978</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2014.11.042</pub-id>
<pub-id pub-id-type="pmid">25578997</pub-id>
</element-citation>
</ref>
<ref id="B43-antioxidants-08-00436">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baardman</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Kerstjens-Frederikse</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Corpeleijn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>de Walle</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Hofstra</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>M.K.</given-names>
</name>
</person-group>
<article-title>Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: Evidence for interaction?</article-title>
<source/>Heart
          <year>2012</year>
<volume>98</volume>
<fpage>474</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="doi">10.1136/heartjnl-2011-300822</pub-id>
<pub-id pub-id-type="pmid">22294555</pub-id>
</element-citation>
</ref>
<ref id="B44-antioxidants-08-00436">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Association between maternal body mass index and congenital heart defects in offspring: A systematic review</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2014</year>
<volume>211</volume>
<fpage>91</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2014.03.028</pub-id>
<pub-id pub-id-type="pmid">24631708</pub-id>
</element-citation>
</ref>
<ref id="B45-antioxidants-08-00436">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waller</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Canfield</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Siega-Riz</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Gallaway</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
<collab>National Birth Defects Prevention Study</collab>
</person-group>
<article-title>Prepregnancy obesity as a risk factor for structural birth defects</article-title>
<source/>Arch. Pediatr. Adolesc. Med.
          <year>2007</year>
<volume>161</volume>
<fpage>745</fpage>
<lpage>750</lpage>
<pub-id pub-id-type="doi">10.1001/archpedi.161.8.745</pub-id>
<pub-id pub-id-type="pmid">17679655</pub-id>
</element-citation>
</ref>
<ref id="B46-antioxidants-08-00436">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>W.D.</given-names>
</name>
<name>
<surname>Healy-Profitos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arbour</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Association Between Preeclampsia and Congenital Heart Defects</article-title>
<source/>JAMA
          <year>2015</year>
<volume>314</volume>
<fpage>1588</fpage>
<lpage>1598</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2015.12505</pub-id>
<pub-id pub-id-type="pmid">26501535</pub-id>
</element-citation>
</ref>
<ref id="B47-antioxidants-08-00436">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Binongo</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Kancherla</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Maternal chlamydia infection during pregnancy and risk of cyanotic congenital heart defects in the offspring</article-title>
<source/>Matern. Child Health J.
          <year>2016</year>
<volume>20</volume>
<fpage>66</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1007/s10995-015-1804-0</pub-id>
<pub-id pub-id-type="pmid">26156829</pub-id>
</element-citation>
</ref>
<ref id="B48-antioxidants-08-00436">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oster</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Riehle-Colarusso</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>An update on cardiovascular malformations in congenital rubella syndrome</article-title>
<source/>Birth Defects Res. A
          <year>2010</year>
<volume>88</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20621</pub-id>
<pub-id pub-id-type="pmid">19697432</pub-id>
</element-citation>
</ref>
<ref id="B49-antioxidants-08-00436">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of symptomatic congenital heart disease in Tibetan school children</article-title>
<source/>Am. J. Cardiol.
          <year>2013</year>
<volume>112</volume>
<fpage>1468</fpage>
<lpage>1470</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjcard.2013.07.028</pub-id>
<pub-id pub-id-type="pmid">24012023</pub-id>
</element-citation>
</ref>
<ref id="B50-antioxidants-08-00436">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoang</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Marengo</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Canfield</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Agopian</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Original findings and updated aeta-analysis for the association between maternal diabetes and risk for congenital heart disease phenotypes</article-title>
<source/>Am. J. Epidemiol.
          <year>2017</year>
<volume>186</volume>
<fpage>118</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kwx033</pub-id>
<pub-id pub-id-type="pmid">28505225</pub-id>
</element-citation>
</ref>
<ref id="B51-antioxidants-08-00436">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wren</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Birrell</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hawthorne</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Cardiovascular malformations in infants of diabetic mothers</article-title>
<source/>Heart
          <year>2003</year>
<volume>89</volume>
<fpage>1217</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1136/heart.89.10.1217</pub-id>
<pub-id pub-id-type="pmid">12975424</pub-id>
</element-citation>
</ref>
<ref id="B52-antioxidants-08-00436">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkins</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feinstein</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Botto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Elixson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Warnes</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>C.L.</given-names>
</name>
<collab>American Heart Association Council on Cardiovascular Disease in the Young</collab>
</person-group>
<article-title>Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics</article-title>
<source/>Circulation
          <year>2007</year>
<volume>115</volume>
<fpage>2995</fpage>
<lpage>3014</lpage>
<pub-id pub-id-type="pmid">17519397</pub-id>
</element-citation>
</ref>
<ref id="B53-antioxidants-08-00436">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loffredo</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Ferencz</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Maternal diabetes: An independent risk factor for major cardiovascular malformations with increased mortality of affected infants</article-title>
<source/>Teratology
          <year>2001</year>
<volume>64</volume>
<fpage>98</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1002/tera.1051</pub-id>
<pub-id pub-id-type="pmid">11460261</pub-id>
</element-citation>
</ref>
<ref id="B54-antioxidants-08-00436">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Karuranga</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>da Rocha Fernandes</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Ohlrogge</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Malanda</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2018</year>
<volume>138</volume>
<fpage>271</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2018.02.023</pub-id>
<pub-id pub-id-type="pmid">29496507</pub-id>
</element-citation>
</ref>
<ref id="B55-antioxidants-08-00436">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olokoba</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Obateru</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Olokoba</surname>
<given-names>L.B.</given-names>
</name>
</person-group>
<article-title>Type 2 diabetes mellitus: A review of current trends</article-title>
<source/>Oman Med. J.
          <year>2012</year>
<volume>27</volume>
<fpage>269</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.5001/omj.2012.68</pub-id>
<pub-id pub-id-type="pmid">23071876</pub-id>
</element-citation>
</ref>
<ref id="B56-antioxidants-08-00436">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forouhi</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Wareham</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Epidemiology of Diabetes</article-title>
<source/>Medicine
          <year>2014</year>
<volume>42</volume>
<fpage>698</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1016/j.mpmed.2014.09.007</pub-id>
<pub-id pub-id-type="pmid">25568613</pub-id>
</element-citation>
</ref>
<ref id="B57-antioxidants-08-00436">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dabelea</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mayer-Davis</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Saydah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Imperatore</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Divers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Badaru</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Talton</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Crume</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009</article-title>
<source/>JAMA
          <year>2014</year>
<volume>311</volume>
<fpage>1778</fpage>
<lpage>1786</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.3201</pub-id>
<pub-id pub-id-type="pmid">24794371</pub-id>
</element-citation>
</ref>
<ref id="B58-antioxidants-08-00436">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaCoursiere</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Bloebaum</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Varner</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2005</year>
<volume>192</volume>
<fpage>832</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2004.11.034</pub-id>
<pub-id pub-id-type="pmid">15746679</pub-id>
</element-citation>
</ref>
<ref id="B59-antioxidants-08-00436">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bardenheier</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Imperatore</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gilboa</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Geiss</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Saydah</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Gregg</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Trends in gestational diabetes among hospital deliveries in 19 U.S. States, 2000–2010</article-title>
<source/>Am. J. Prev. Med.
          <year>2015</year>
<volume>49</volume>
<fpage>12</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.amepre.2015.01.026</pub-id>
<pub-id pub-id-type="pmid">26094225</pub-id>
</element-citation>
</ref>
<ref id="B60-antioxidants-08-00436">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albrecht</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Kuklina</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Bansil</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Whiteman</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Kourtis</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Posner</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Callaghan</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Diabetes trends among delivery hospitalizations in the U.S., 1994–2004</article-title>
<source/>Diabetes Care
          <year>2010</year>
<volume>33</volume>
<fpage>768</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="doi">10.2337/dc09-1801</pub-id>
<pub-id pub-id-type="pmid">20067968</pub-id>
</element-citation>
</ref>
<ref id="B61-antioxidants-08-00436">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackin</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kerssens</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colhoun</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Leese</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Philip</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Group</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Diabetes and pregnancy: National trends over a 15 year period</article-title>
<source/>Diabetologia
          <year>2018</year>
<volume>61</volume>
<fpage>1081</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-017-4529-3</pub-id>
<pub-id pub-id-type="pmid">29322220</pub-id>
</element-citation>
</ref>
<ref id="B62-antioxidants-08-00436">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abu-Sulaiman</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Subaih</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Congenital heart disease in infants of diabetic mothers: Echocardiographic study</article-title>
<source/>Pediatr. Cardiol.
          <year>2004</year>
<volume>25</volume>
<fpage>137</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1007/s00246-003-0538-8</pub-id>
<pub-id pub-id-type="pmid">14648003</pub-id>
</element-citation>
</ref>
<ref id="B63-antioxidants-08-00436">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evers</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>de Valk</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>G.H.</given-names>
</name>
</person-group>
<article-title>Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands</article-title>
<source/>BMJ
          <year>2004</year>
<volume>328</volume>
<fpage>915</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.38043.583160.EE</pub-id>
<pub-id pub-id-type="pmid">15066886</pub-id>
</element-citation>
</ref>
<ref id="B64-antioxidants-08-00436">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macintosh</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Modder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Acolet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Golightly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: Population based study</article-title>
<source/>Br. Med. J.
          <year>2006</year>
<volume>333</volume>
<fpage>177</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.38856.692986.AE</pub-id>
<pub-id pub-id-type="pmid">16782722</pub-id>
</element-citation>
</ref>
<ref id="B65-antioxidants-08-00436">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheehan</surname>
<given-names>P.Q.</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>McGravey</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>E.O.</given-names>
</name>
</person-group>
<article-title>Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers</article-title>
<source/>Clin. Pediatr.
          <year>1986</year>
<volume>25</volume>
<fpage>266</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1177/000992288602500507</pub-id>
<pub-id pub-id-type="pmid">3698447</pub-id>
</element-citation>
</ref>
<ref id="B66-antioxidants-08-00436">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Joffe</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Fatal hypertrophic cardiomyopathy in an infant of a diabetic mother</article-title>
<source/>Pediatr. Cardiol.
          <year>1990</year>
<volume>11</volume>
<fpage>211</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1007/BF02238369</pub-id>
<pub-id pub-id-type="pmid">2274449</pub-id>
</element-citation>
</ref>
<ref id="B67-antioxidants-08-00436">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sardesai</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Fatal hypertrophic cardiomyopathy in the fetus of a woman with Diabetes</article-title>
<source/>Obstet. Gynecol.
          <year>2001</year>
<volume>98</volume>
<fpage>925</fpage>
<lpage>927</lpage>
<pub-id pub-id-type="pmid">11704206</pub-id>
</element-citation>
</ref>
<ref id="B68-antioxidants-08-00436">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Holloway</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kelehan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McAuliffe</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Cardiomyopathy and cardiomegaly in stillborn infants of diabetic mothers</article-title>
<source/>Pediatr. Dev. Pathol.
          <year>2008</year>
<volume>11</volume>
<fpage>10</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.2350/07-05-0277.1</pub-id>
<pub-id pub-id-type="pmid">18237240</pub-id>
</element-citation>
</ref>
<ref id="B69-antioxidants-08-00436">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kinsley</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Firth</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McAuliffe</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Effect of pregestational diabetes mellitus on fetal cardiac function and structure</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2008</year>
<volume>199</volume>
<fpage>312</fpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2008.07.016</pub-id>
<pub-id pub-id-type="pmid">18771996</pub-id>
</element-citation>
</ref>
<ref id="B70-antioxidants-08-00436">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Kinsley</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>McAuliffe</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Heart rate variability in neonates of type 1 diabetic pregnancy</article-title>
<source/>Early Hum. Dev.
          <year>2016</year>
<volume>92</volume>
<fpage>51</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2015.11.003</pub-id>
<pub-id pub-id-type="pmid">26658058</pub-id>
</element-citation>
</ref>
<ref id="B71-antioxidants-08-00436">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sarno</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zullo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maruotti</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Pregestational diabetes and fetal heart rate in the first trimester of pregnancy</article-title>
<source/>Eur. J. Obstet. Gynecol. Reprod. Biol.
          <year>2019</year>
<volume>232</volume>
<fpage>30</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejogrb.2018.11.003</pub-id>
<pub-id pub-id-type="pmid">30465928</pub-id>
</element-citation>
</ref>
<ref id="B72-antioxidants-08-00436">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tincello</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Walkinshaw</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Computerised analysis of fetal heart rate recordings in maternal type I diabetes mellitus</article-title>
<source/>BJOG
          <year>2001</year>
<volume>108</volume>
<fpage>853</fpage>
<lpage>857</lpage>
<pub-id pub-id-type="pmid">11510712</pub-id>
</element-citation>
</ref>
<ref id="B73-antioxidants-08-00436">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacharova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Krivosikova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wsolova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gajdos</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Alterations in the QRS complex in the offspring of patients with metabolic syndrome and diabetes mellitus: Early evidence of cardiovascular pathology</article-title>
<source/>J. Electrocardiol.
          <year>2012</year>
<volume>45</volume>
<fpage>244</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.jelectrocard.2012.02.004</pub-id>
<pub-id pub-id-type="pmid">22520960</pub-id>
</element-citation>
</ref>
<ref id="B74-antioxidants-08-00436">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>The developmental origins of adult disease</article-title>
<source/>J. Am. Coll. Nutr.
          <year>2004</year>
<volume>23</volume>
<fpage>588S</fpage>
<lpage>595S</lpage>
<pub-id pub-id-type="doi">10.1080/07315724.2004.10719428</pub-id>
<pub-id pub-id-type="pmid">15640511</pub-id>
</element-citation>
</ref>
<ref id="B75-antioxidants-08-00436">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMillen</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming</article-title>
<source/>Physiol. Rev.
          <year>2005</year>
<volume>85</volume>
<fpage>571</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00053.2003</pub-id>
<pub-id pub-id-type="pmid">15788706</pub-id>
</element-citation>
</ref>
<ref id="B76-antioxidants-08-00436">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lock</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Botting</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Tellam</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Adverse Intrauterine Environment and Cardiac miRNA Expression</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<elocation-id>2628</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms18122628</pub-id>
<pub-id pub-id-type="pmid">29210999</pub-id>
</element-citation>
</ref>
<ref id="B77-antioxidants-08-00436">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kendrick</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Reliability of reporting of self-monitoring of blood glucose in pregnant women</article-title>
<source/>J. Obstet. Gynecol. Neonatal Nurs.
          <year>2005</year>
<volume>34</volume>
<fpage>329</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1177/0884217505276306</pub-id>
</element-citation>
</ref>
<ref id="B78-antioxidants-08-00436">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunachie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chamnan</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The double burden of diabetes and global infection in low and middle-income countries</article-title>
<source/>Trans. R. Soc. Trop. Med. Hyg.
          <year>2019</year>
<volume>113</volume>
<fpage>56</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1093/trstmh/try124</pub-id>
<pub-id pub-id-type="pmid">30517697</pub-id>
</element-citation>
</ref>
<ref id="B79-antioxidants-08-00436">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitzmiller</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Wallerstein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Preconception care for women with diabetes and prevention of major congenital malformations</article-title>
<source/>Birth Defects Res. A
          <year>2010</year>
<volume>88</volume>
<fpage>791</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20734</pub-id>
</element-citation>
</ref>
<ref id="B80-antioxidants-08-00436">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Quintero</surname>
<given-names>V.H.</given-names>
</name>
<name>
<surname>Istwan</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Rhea</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stanziano</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational Diabetes</article-title>
<source/>Diabetes Care
          <year>2007</year>
<volume>30</volume>
<fpage>467</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="doi">10.2337/dc06-1875</pub-id>
<pub-id pub-id-type="pmid">17327306</pub-id>
</element-citation>
</ref>
<ref id="B81-antioxidants-08-00436">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jovanovic</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wintfeld</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy</article-title>
<source/>Diabetes Metab. Res. Rev.
          <year>2015</year>
<volume>31</volume>
<fpage>707</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="doi">10.1002/dmrr.2656</pub-id>
<pub-id pub-id-type="pmid">25899622</pub-id>
</element-citation>
</ref>
<ref id="B82-antioxidants-08-00436">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksen</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Damm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mathiesen</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Ringholm</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The prevalence of congenital malformations is still higher in pregnant women with pregestational diabetes despite near-normal HbA1c: A literature review</article-title>
<source/>J. Matern. Fetal Neonatal Med.
          <year>2019</year>
<volume>32</volume>
<fpage>1225</fpage>
<lpage>1229</lpage>
<pub-id pub-id-type="doi">10.1080/14767058.2017.1402880</pub-id>
<pub-id pub-id-type="pmid">29172827</pub-id>
</element-citation>
</ref>
<ref id="B83-antioxidants-08-00436">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeRuiter</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Poelmann</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>VanderPlas-de Vries</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mentink</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Gittenberger-de Groot</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>The development of the myocardium and endocardium in mouse embryos</article-title>
<source/>Anat. Embryol.
          <year>1992</year>
<volume>185</volume>
<fpage>461</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1007/BF00174084</pub-id>
<pub-id pub-id-type="pmid">1567022</pub-id>
</element-citation>
</ref>
<ref id="B84-antioxidants-08-00436">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>E.N.</given-names>
</name>
</person-group>
<article-title>Gene regulatory networks in the evolution and development of the Heart</article-title>
<source/>Science
          <year>2006</year>
<volume>313</volume>
<fpage>1922</fpage>
<lpage>1927</lpage>
<pub-id pub-id-type="doi">10.1126/science.1132292</pub-id>
<pub-id pub-id-type="pmid">17008524</pub-id>
</element-citation>
</ref>
<ref id="B85-antioxidants-08-00436">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sizarov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ya</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Boer</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Lamers</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Christoffels</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Moorman</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Formation of the building plan of the human heart: Morphogenesis, growth, and differentiation</article-title>
<source/>Circulation
          <year>2011</year>
<volume>123</volume>
<fpage>1125</fpage>
<lpage>1135</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.980607</pub-id>
<pub-id pub-id-type="pmid">21403123</pub-id>
</element-citation>
</ref>
<ref id="B86-antioxidants-08-00436">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockhart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wirrig</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wessels</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Extracellular matrix and heart development</article-title>
<source/>Birth Defects Res. A
          <year>2011</year>
<volume>91</volume>
<fpage>535</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20810</pub-id>
<pub-id pub-id-type="pmid">21618406</pub-id>
</element-citation>
</ref>
<ref id="B87-antioxidants-08-00436">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buckingham</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meilhac</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zaffran</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Building the mammalian heart from two sources of myocardial cells</article-title>
<source/>Nat. Rev. Genet.
          <year>2005</year>
<volume>6</volume>
<fpage>826</fpage>
<lpage>835</lpage>
<pub-id pub-id-type="doi">10.1038/nrg1710</pub-id>
<pub-id pub-id-type="pmid">16304598</pub-id>
</element-citation>
</ref>
<ref id="B88-antioxidants-08-00436">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meilhac</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Buckingham</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>The deployment of cell lineages that form the mammalian heart</article-title>
<source/>Nat. Rev. Cardiol.
          <year>2018</year>
<volume>15</volume>
<fpage>705</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1038/s41569-018-0086-9</pub-id>
<pub-id pub-id-type="pmid">30266935</pub-id>
</element-citation>
</ref>
<ref id="B89-antioxidants-08-00436">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single-cell transcriptome analysis maps the developmental track of the human heart</article-title>
<source/>Cell Rep.
          <year>2019</year>
<volume>26</volume>
<fpage>1934</fpage>
<lpage>1950</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.079</pub-id>
<pub-id pub-id-type="pmid">30759401</pub-id>
</element-citation>
</ref>
<ref id="B90-antioxidants-08-00436">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruneau</surname>
<given-names>B.G.</given-names>
</name>
</person-group>
<article-title>The developmental genetics of congenital heart disease</article-title>
<source/>Nature
          <year>2008</year>
<volume>451</volume>
<fpage>943</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="doi">10.1038/nature06801</pub-id>
<pub-id pub-id-type="pmid">18288184</pub-id>
</element-citation>
</ref>
<ref id="B91-antioxidants-08-00436">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Yutzey</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Transcription factors and congenital heart defects</article-title>
<source/>Annu. Rev. Physiol.
          <year>2006</year>
<volume>68</volume>
<fpage>97</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.physiol.68.040104.113828</pub-id>
<pub-id pub-id-type="pmid">16460268</pub-id>
</element-citation>
</ref>
<ref id="B92-antioxidants-08-00436">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kathiriya</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schluterman</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rothrock</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Hirayama-Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5</article-title>
<source/>Nature
          <year>2003</year>
<volume>424</volume>
<fpage>443</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1038/nature01827</pub-id>
<pub-id pub-id-type="pmid">12845333</pub-id>
</element-citation>
</ref>
<ref id="B93-antioxidants-08-00436">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brueckner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Genetics and genomics of congenital heart disease</article-title>
<source/>Circ. Res.
          <year>2017</year>
<volume>120</volume>
<fpage>923</fpage>
<lpage>940</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309140</pub-id>
<pub-id pub-id-type="pmid">28302740</pub-id>
</element-citation>
</ref>
<ref id="B94-antioxidants-08-00436">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durocher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Charron</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Nemer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors</article-title>
<source/>EMBO J.
          <year>1997</year>
<volume>16</volume>
<fpage>5687</fpage>
<lpage>5696</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/16.18.5687</pub-id>
<pub-id pub-id-type="pmid">9312027</pub-id>
</element-citation>
</ref>
<ref id="B95-antioxidants-08-00436">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furchgott</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Zawadzki</surname>
<given-names>J.V.</given-names>
</name>
</person-group>
<article-title>The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine</article-title>
<source/>Nature
          <year>1980</year>
<volume>288</volume>
<fpage>373</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1038/288373a0</pub-id>
<pub-id pub-id-type="pmid">6253831</pub-id>
</element-citation>
</ref>
<ref id="B96-antioxidants-08-00436">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farah</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>L.Y.M.</given-names>
</name>
<name>
<surname>Balligand</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Nitric oxide signalling in cardiovascular health and disease</article-title>
<source/>Nat. Rev. Cardiol.
          <year>2018</year>
<volume>15</volume>
<fpage>292</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1038/nrcardio.2017.224</pub-id>
<pub-id pub-id-type="pmid">29388567</pub-id>
</element-citation>
</ref>
<ref id="B97-antioxidants-08-00436">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanhoutte</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Thirty years of saying NO: Sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator</article-title>
<source/>Circ. Res.
          <year>2016</year>
<volume>119</volume>
<fpage>375</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.306531</pub-id>
<pub-id pub-id-type="pmid">27390338</pub-id>
</element-citation>
</ref>
<ref id="B98-antioxidants-08-00436">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuehr</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthase enzymology in the 20 years after the Nobel Prize</article-title>
<source/>Br. J. Pharmacol.
          <year>2019</year>
<volume>176</volume>
<fpage>177</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1111/bph.14533</pub-id>
<pub-id pub-id-type="pmid">30402946</pub-id>
</element-citation>
</ref>
<ref id="B99-antioxidants-08-00436">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knowles</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Moncada</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthases in mammals</article-title>
<source/>Biochem. J.
          <year>1994</year>
<volume>298</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1042/bj2980249</pub-id>
<pub-id pub-id-type="pmid">7510950</pub-id>
</element-citation>
</ref>
<ref id="B100-antioxidants-08-00436">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francis</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Busch</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Corbin</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Sibley</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action</article-title>
<source/>Pharmacol. Rev.
          <year>2010</year>
<volume>62</volume>
<fpage>525</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1124/pr.110.002907</pub-id>
<pub-id pub-id-type="pmid">20716671</pub-id>
</element-citation>
</ref>
<ref id="B101-antioxidants-08-00436">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erwin</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Golan</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells</article-title>
<source/>J. Biol. Chem.
          <year>2005</year>
<volume>280</volume>
<fpage>19888</fpage>
<lpage>19894</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M413058200</pub-id>
<pub-id pub-id-type="pmid">15774480</pub-id>
</element-citation>
</ref>
<ref id="B102-antioxidants-08-00436">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>NOing the heart: Role of nitric oxide synthase-3 in heart development</article-title>
<source/>Differentiation
          <year>2012</year>
<volume>84</volume>
<fpage>54</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.diff.2012.04.004</pub-id>
<pub-id pub-id-type="pmid">22579300</pub-id>
</element-citation>
</ref>
<ref id="B103-antioxidants-08-00436">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bendall</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McNeill</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Channon</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Tetrahydrobiopterin in cardiovascular health and disease</article-title>
<source/>Antioxid. Redox Signal
          <year>2014</year>
<volume>20</volume>
<fpage>3040</fpage>
<lpage>3077</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2013.5566</pub-id>
<pub-id pub-id-type="pmid">24294830</pub-id>
</element-citation>
</ref>
<ref id="B104-antioxidants-08-00436">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werner</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Thony</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Tetrahydrobiopterin: Biochemistry and pathophysiology</article-title>
<source/>Biochem. J.
          <year>2011</year>
<volume>438</volume>
<fpage>397</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20110293</pub-id>
<pub-id pub-id-type="pmid">21867484</pub-id>
</element-citation>
</ref>
<ref id="B105-antioxidants-08-00436">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugiyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>12691</fpage>
<lpage>12700</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M809295200</pub-id>
<pub-id pub-id-type="pmid">19286667</pub-id>
</element-citation>
</ref>
<ref id="B106-antioxidants-08-00436">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuaiphichai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>McNeill</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hale</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Trelfa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Channon</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in resistance arteries: Studies in endothelial cell tetrahydrobiopterin-deficient mice</article-title>
<source/>Br. J. Pharmacol.
          <year>2017</year>
<volume>174</volume>
<fpage>657</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1111/bph.13728</pub-id>
<pub-id pub-id-type="pmid">28128438</pub-id>
</element-citation>
</ref>
<ref id="B107-antioxidants-08-00436">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forstermann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Sessa</surname>
<given-names>W.C.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthases: Regulation and function</article-title>
<source/>Eur. Heart J.
          <year>2012</year>
<volume>33</volume>
<fpage>829</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehr304</pub-id>
<pub-id pub-id-type="pmid">21890489</pub-id>
</element-citation>
</ref>
<ref id="B108-antioxidants-08-00436">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>Peroxynitrite-dependent zinc release and inactivation of guanosine 5′-triphosphate cyclohydrolase 1 instigate its ubiquitination in Diabetes</article-title>
<source/>Diabetes
          <year>2013</year>
<volume>62</volume>
<fpage>4247</fpage>
<lpage>4256</lpage>
<pub-id pub-id-type="doi">10.2337/db13-0751</pub-id>
<pub-id pub-id-type="pmid">23974923</pub-id>
</element-citation>
</ref>
<ref id="B109-antioxidants-08-00436">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beckman</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1990</year>
<volume>87</volume>
<fpage>1620</fpage>
<lpage>1624</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.87.4.1620</pub-id>
<pub-id pub-id-type="pmid">2154753</pub-id>
</element-citation>
</ref>
<ref id="B110-antioxidants-08-00436">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ischiropoulos</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Al-Mehdi</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Peroxynitrite-mediated oxidative protein modifications</article-title>
<source/>FEBS Lett.
          <year>1995</year>
<volume>364</volume>
<fpage>279</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1016/0014-5793(95)00307-U</pub-id>
<pub-id pub-id-type="pmid">7758583</pub-id>
</element-citation>
</ref>
<ref id="B111-antioxidants-08-00436">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chalupsky</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2005</year>
<volume>102</volume>
<fpage>9056</fpage>
<lpage>9061</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0409594102</pub-id>
<pub-id pub-id-type="pmid">15941833</pub-id>
</element-citation>
</ref>
<ref id="B112-antioxidants-08-00436">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pucciarelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Montecchia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lupidi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Eleuteri</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fioretti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Angeletti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Peroxynitrite-mediated oxidation of the C85S/C152E mutant of dihydrofolate reductase from Escherichia coli: Functional and structural effects</article-title>
<source/>Arch. Biochem. Biophys.
          <year>2005</year>
<volume>434</volume>
<fpage>221</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1016/j.abb.2004.11.008</pub-id>
<pub-id pub-id-type="pmid">15639221</pub-id>
</element-citation>
</ref>
<ref id="B113-antioxidants-08-00436">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasquez-Vivar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kalyanaraman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Martasek</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The role of tetrahydrobiopterin in superoxide generation from eNOS: Enzymology and physiological implications</article-title>
<source/>Free Radic. Res.
          <year>2003</year>
<volume>37</volume>
<fpage>121</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1080/1071576021000040655</pub-id>
<pub-id pub-id-type="pmid">12653200</pub-id>
</element-citation>
</ref>
<ref id="B114-antioxidants-08-00436">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youn</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Bone mProtein 4 mediates NOX1-dependent eNOS uncoupling, endothelial dysfunction, and COX2 induction in type 2 diabetes mellitus</article-title>
<source/>Mol. Endocrinol.
          <year>2015</year>
<volume>29</volume>
<fpage>1123</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1210/ME.2014-1313</pub-id>
<pub-id pub-id-type="pmid">26121233</pub-id>
</element-citation>
</ref>
<ref id="B115-antioxidants-08-00436">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tokutomi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nako</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim-Mitsuyama</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2010</year>
<volume>403</volume>
<fpage>258</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.11.008</pub-id>
<pub-id pub-id-type="pmid">21059340</pub-id>
</element-citation>
</ref>
<ref id="B116-antioxidants-08-00436">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassuto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Czikora</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V.S.</given-names>
</name>
<name>
<surname>Kamath</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Belin de Chantemele</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Feher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Bagi</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients</article-title>
<source/>Diabetes
          <year>2014</year>
<volume>63</volume>
<fpage>1381</fpage>
<lpage>1393</lpage>
<pub-id pub-id-type="doi">10.2337/db13-0577</pub-id>
<pub-id pub-id-type="pmid">24353182</pub-id>
</element-citation>
</ref>
<ref id="B117-antioxidants-08-00436">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>eNOS uncoupling and endothelial dysfunction in aged vessels</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2009</year>
<volume>297</volume>
<fpage>H1829</fpage>
<lpage>H1836</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00230.2009</pub-id>
<pub-id pub-id-type="pmid">19767531</pub-id>
</element-citation>
</ref>
<ref id="B118-antioxidants-08-00436">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Pershad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>McGraw</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Zambrano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Krass</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Emrich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Iyamu</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R)</article-title>
<source/>Naunyn Schmiedeberg’s Arch. Pharmacol.
          <year>2012</year>
<volume>385</volume>
<fpage>27</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1007/s00210-011-0693-z</pub-id>
<pub-id pub-id-type="pmid">21947254</pub-id>
</element-citation>
</ref>
<ref id="B119-antioxidants-08-00436">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takimoto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Champion</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Tavazzi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lazzarino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Paolocci</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gabrielson</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load</article-title>
<source/>J. Clin. Investig.
          <year>2005</year>
<volume>115</volume>
<fpage>1221</fpage>
<lpage>1231</lpage>
<pub-id pub-id-type="doi">10.1172/JCI21968</pub-id>
<pub-id pub-id-type="pmid">15841206</pub-id>
</element-citation>
</ref>
<ref id="B120-antioxidants-08-00436">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alp</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Mussa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guzik</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jefferson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rockett</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Channon</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression</article-title>
<source/>J. Clin. Investig.
          <year>2003</year>
<volume>112</volume>
<fpage>725</fpage>
<lpage>735</lpage>
<pub-id pub-id-type="doi">10.1172/JCI17786</pub-id>
<pub-id pub-id-type="pmid">12952921</pub-id>
</element-citation>
</ref>
<ref id="B121-antioxidants-08-00436">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porkert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Cheema</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Niessner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kolm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tetrahydrobiopterin: A novel antihypertensive therapy</article-title>
<source/>J. Hum. Hypertens.
          <year>2008</year>
<volume>22</volume>
<fpage>401</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jhh.1002329</pub-id>
<pub-id pub-id-type="pmid">18322548</pub-id>
</element-citation>
</ref>
<ref id="B122-antioxidants-08-00436">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosentino</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hurlimann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Delli Gatti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chenevard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Alp</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Channon</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Eto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Enseleit</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia</article-title>
<source/>Heart
          <year>2008</year>
<volume>94</volume>
<fpage>487</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1136/hrt.2007.122184</pub-id>
<pub-id pub-id-type="pmid">17916662</pub-id>
</element-citation>
</ref>
<ref id="B123-antioxidants-08-00436">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worthley</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Kanani</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Goodhart</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries</article-title>
<source/>Cardiovasc. Res.
          <year>2007</year>
<volume>76</volume>
<fpage>539</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1016/j.cardiores.2007.07.009</pub-id>
<pub-id pub-id-type="pmid">17689509</pub-id>
</element-citation>
</ref>
<ref id="B124-antioxidants-08-00436">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunnington</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Van Assche</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shirodaria</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kylintireas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Antoniades</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Margaritis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cerrato</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease</article-title>
<source/>Circulation
          <year>2012</year>
<volume>125</volume>
<fpage>1356</fpage>
<lpage>1366</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.038919</pub-id>
<pub-id pub-id-type="pmid">22315282</pub-id>
</element-citation>
</ref>
<ref id="B125-antioxidants-08-00436">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase</article-title>
<source/>Circulation
          <year>2002</year>
<volume>106</volume>
<fpage>873</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.0000024114.82981.EA</pub-id>
<pub-id pub-id-type="pmid">12176963</pub-id>
</element-citation>
</ref>
<ref id="B126-antioxidants-08-00436">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fleischmann</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Lorke</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Andressen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hops</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hescheler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Addicks</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthase expression and role during cardiomyogenesis</article-title>
<source/>Cardiovasc. Res.
          <year>1999</year>
<volume>43</volume>
<fpage>675</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="doi">10.1016/S0008-6363(99)00160-1</pub-id>
<pub-id pub-id-type="pmid">10690339</pub-id>
</element-citation>
</ref>
<ref id="B127-antioxidants-08-00436">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanno</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Sallam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shears</surname>
<given-names>L.L.</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Billiar</surname>
<given-names>T.R.</given-names>
</name>
</person-group>
<article-title>Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>12277</fpage>
<lpage>12281</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0401557101</pub-id>
<pub-id pub-id-type="pmid">15304656</pub-id>
</element-citation>
</ref>
<ref id="B128-antioxidants-08-00436">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Biendarra</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Terzic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Nos3−/− iPSCs model concordant signatures of in utero cardiac pathogenesis</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2015</year>
<volume>87</volume>
<fpage>228</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.08.021</pub-id>
<pub-id pub-id-type="pmid">26344701</pub-id>
</element-citation>
</ref>
<ref id="B129-antioxidants-08-00436">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadeau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Georges</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Laforest</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yamak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beauregard</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paradis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Andelfinger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nemer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>19356</fpage>
<lpage>19361</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0914888107</pub-id>
<pub-id pub-id-type="pmid">20974940</pub-id>
</element-citation>
</ref>
<ref id="B130-antioxidants-08-00436">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.D.</given-names>
</name>
<name>
<surname>Courtman</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase</article-title>
<source/>Circulation
          <year>2000</year>
<volume>101</volume>
<fpage>2345</fpage>
<lpage>2348</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.101.20.2345</pub-id>
<pub-id pub-id-type="pmid">10821808</pub-id>
</element-citation>
</ref>
<ref id="B131-antioxidants-08-00436">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthase-3 promotes embryonic development of atrioventricular valves</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e77611</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0077611</pub-id>
<pub-id pub-id-type="pmid">24204893</pub-id>
</element-citation>
</ref>
<ref id="B132-antioxidants-08-00436">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Accaoui</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Hajj</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Doshi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>K.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2014</year>
<volume>306</volume>
<fpage>H1302</fpage>
<lpage>H1313</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00392.2013</pub-id>
<pub-id pub-id-type="pmid">24610917</pub-id>
</element-citation>
</ref>
<ref id="B133-antioxidants-08-00436">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aicher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Urbich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zeiher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dimmeler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schafers</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Endothelial nitric oxide synthase in bicuspid aortic valve disease</article-title>
<source/>Ann. Thorac. Surg.
          <year>2007</year>
<volume>83</volume>
<fpage>1290</fpage>
<lpage>1294</lpage>
<pub-id pub-id-type="doi">10.1016/j.athoracsur.2006.11.086</pub-id>
<pub-id pub-id-type="pmid">17383329</pub-id>
</element-citation>
</ref>
<ref id="B134-antioxidants-08-00436">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razavi</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Modulation of apoptosis by nitric oxide: Implications in myocardial ischemia and heart failure</article-title>
<source/>Pharmacol. Ther.
          <year>2005</year>
<volume>106</volume>
<fpage>147</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.11.006</pub-id>
<pub-id pub-id-type="pmid">15866317</pub-id>
</element-citation>
</ref>
<ref id="B135-antioxidants-08-00436">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimmeler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zeiher</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells</article-title>
<source/>Arterioscler. Thromb. Vasc. Biol.
          <year>1999</year>
<volume>19</volume>
<fpage>656</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1161/01.ATV.19.3.656</pub-id>
<pub-id pub-id-type="pmid">10073970</pub-id>
</element-citation>
</ref>
<ref id="B136-antioxidants-08-00436">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepic</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation</article-title>
<source/>Am. J. Physiol. Cell Physiol.
          <year>2006</year>
<volume>291</volume>
<fpage>C1240</fpage>
<lpage>C1246</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.00092.2006</pub-id>
<pub-id pub-id-type="pmid">16822949</pub-id>
</element-citation>
</ref>
<ref id="B137-antioxidants-08-00436">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Poelmann</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gittenberger-de Groot</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Nitric oxide synthase-3 deficiency results in hypoplastic coronary arteries and postnatal myocardial infarction</article-title>
<source/>Eur. Heart J.
          <year>2014</year>
<volume>35</volume>
<fpage>920</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehs306</pub-id>
<pub-id pub-id-type="pmid">23048191</pub-id>
</element-citation>
</ref>
<ref id="B138-antioxidants-08-00436">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldosari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Awad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>E.O.</given-names>
</name>
<name>
<surname>Sellke</surname>
<given-names>F.W.</given-names>
</name>
<name>
<surname>Abid</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Subcellular reactive oxygen species (ROS) in cardiovascular pathophysiology</article-title>
<source/>Antioxidants
          <year>2018</year>
<volume>7</volume>
<elocation-id>14</elocation-id>
<pub-id pub-id-type="doi">10.3390/antiox7010014</pub-id>
</element-citation>
</ref>
<ref id="B139-antioxidants-08-00436">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaludercic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Deshwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Lisa</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species and redox compartmentalization</article-title>
<source/>Front. Physiol.
          <year>2014</year>
<volume>5</volume>
<fpage>285</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00285</pub-id>
<pub-id pub-id-type="pmid">25161621</pub-id>
</element-citation>
</ref>
<ref id="B140-antioxidants-08-00436">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brieger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schiavone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>F.J.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Krause</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species: From health to disease</article-title>
<source/>Swiss Med. Wkly.
          <year>2012</year>
<volume>142</volume>
<fpage>w13659</fpage>
<pub-id pub-id-type="doi">10.4414/smw.2012.13659</pub-id>
<pub-id pub-id-type="pmid">22903797</pub-id>
</element-citation>
</ref>
<ref id="B141-antioxidants-08-00436">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Appenzeller-Herzog</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Banhegyi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bogeski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Delaunay-Moisan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forman</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Gorlach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kietzmann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Laurindo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Margittai</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transit of H<sub>2</sub>O<sub>2</sub> across the endoplasmic reticulum membrane is not sluggish</article-title>
<source/>Free Radic. Biol. Med.
          <year>2016</year>
<volume>94</volume>
<fpage>157</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.02.030</pub-id>
<pub-id pub-id-type="pmid">26928585</pub-id>
</element-citation>
</ref>
<ref id="B142-antioxidants-08-00436">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moller</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Cuevasanta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Orrico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Denicola</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Diffusion and transport of reactive species across cell membranes</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2019</year>
<volume>1127</volume>
<fpage>3</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">31140168</pub-id>
</element-citation>
</ref>
<ref id="B143-antioxidants-08-00436">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Oxidative damage to RNA: Mechanisms, consequences, and diseases</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2010</year>
<volume>67</volume>
<fpage>1817</fpage>
<lpage>1829</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-010-0277-y</pub-id>
<pub-id pub-id-type="pmid">20148281</pub-id>
</element-citation>
</ref>
<ref id="B144-antioxidants-08-00436">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress</article-title>
<source/>Redox Biol.
          <year>2017</year>
<volume>11</volume>
<fpage>613</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2016.12.035</pub-id>
<pub-id pub-id-type="pmid">28110218</pub-id>
</element-citation>
</ref>
<ref id="B145-antioxidants-08-00436">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shimokawa</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis</article-title>
<source/>Free Radic. Biol. Med.
          <year>2017</year>
<volume>109</volume>
<fpage>4</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.12.019</pub-id>
<pub-id pub-id-type="pmid">27988339</pub-id>
</element-citation>
</ref>
<ref id="B146-antioxidants-08-00436">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mackey</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation</article-title>
<source/>Redox Rep.
          <year>2009</year>
<volume>14</volume>
<fpage>102</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1179/135100009X392566</pub-id>
<pub-id pub-id-type="pmid">19490751</pub-id>
</element-citation>
</ref>
<ref id="B147-antioxidants-08-00436">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cadet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Delatour</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Douki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gasparutto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pouget</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Ravanat</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Sauvaigo</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Hydroxyl radicals and DNA base damage</article-title>
<source/>Mutat. Res.
          <year>1999</year>
<volume>424</volume>
<fpage>9</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/S0027-5107(99)00004-4</pub-id>
<pub-id pub-id-type="pmid">10064846</pub-id>
</element-citation>
</ref>
<ref id="B148-antioxidants-08-00436">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakajima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Unoda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kitaoka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hanafusa</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The relation of urinary 8-OHdG, a marker of oxidative stress to DNA, and clinical outcomes for ischemic stroke</article-title>
<source/>Open Neurol. J.
          <year>2012</year>
<volume>6</volume>
<fpage>51</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.2174/1874205X01206010051</pub-id>
<pub-id pub-id-type="pmid">22754596</pub-id>
</element-citation>
</ref>
<ref id="B149-antioxidants-08-00436">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayala</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Arguelles</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal</article-title>
<source/>Oxid. Med. Cell. Longev.
          <year>2014</year>
<volume>2014</volume>
<fpage>360438</fpage>
<pub-id pub-id-type="doi">10.1155/2014/360438</pub-id>
<pub-id pub-id-type="pmid">24999379</pub-id>
</element-citation>
</ref>
<ref id="B150-antioxidants-08-00436">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>D.I.</given-names>
</name>
</person-group>
<article-title>External influences on the fetus and their long-term consequences</article-title>
<source/>Lupus
          <year>2006</year>
<volume>15</volume>
<fpage>794</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1177/0961203306069354</pub-id>
<pub-id pub-id-type="pmid">17153853</pub-id>
</element-citation>
</ref>
<ref id="B151-antioxidants-08-00436">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Developmental regulation in the expression of rat heart glucose transporters</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>1991</year>
<volume>177</volume>
<fpage>1095</fpage>
<lpage>1100</lpage>
<pub-id pub-id-type="doi">10.1016/0006-291X(91)90651-M</pub-id>
<pub-id pub-id-type="pmid">1711843</pub-id>
</element-citation>
</ref>
<ref id="B152-antioxidants-08-00436">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopaschuk</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Jaswal</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation</article-title>
<source/>J. Cardiovasc. Pharmacol.
          <year>2010</year>
<volume>56</volume>
<fpage>130</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1097/FJC.0b013e3181e74a14</pub-id>
<pub-id pub-id-type="pmid">20505524</pub-id>
</element-citation>
</ref>
<ref id="B153-antioxidants-08-00436">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Glucose transporters in cardiac metabolism and hypertrophy</article-title>
<source/>Compr. Physiol.
          <year>2015</year>
<volume>6</volume>
<fpage>331</fpage>
<lpage>351</lpage>
<pub-id pub-id-type="pmid">26756635</pub-id>
</element-citation>
</ref>
<ref id="B154-antioxidants-08-00436">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brownlee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Biochemistry and molecular cell biology of diabetic complications</article-title>
<source/>Nature
          <year>2001</year>
<volume>414</volume>
<fpage>813</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1038/414813a</pub-id>
<pub-id pub-id-type="pmid">11742414</pub-id>
</element-citation>
</ref>
<ref id="B155-antioxidants-08-00436">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Edelstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Yamagishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yorek</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Beebe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Oates</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Hammes</surname>
<given-names>H.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage</article-title>
<source/>Nature
          <year>2000</year>
<volume>404</volume>
<fpage>787</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1038/35008121</pub-id>
<pub-id pub-id-type="pmid">10783895</pub-id>
</element-citation>
</ref>
<ref id="B156-antioxidants-08-00436">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazarewicz</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Dikalova</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Bikineyeva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dikalov</surname>
<given-names>S.I.</given-names>
</name>
</person-group>
<article-title>Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <year>2013</year>
<volume>305</volume>
<fpage>H1131</fpage>
<lpage>H1140</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00063.2013</pub-id>
<pub-id pub-id-type="pmid">23955717</pub-id>
</element-citation>
</ref>
<ref id="B157-antioxidants-08-00436">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and redox regulation on in vitro development of mammalian embryos</article-title>
<source/>J. Reprod. Dev.
          <year>2012</year>
<volume>58</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1262/jrd.11-138N</pub-id>
<pub-id pub-id-type="pmid">22450278</pub-id>
</element-citation>
</ref>
<ref id="B158-antioxidants-08-00436">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreyev</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Kushnareva</surname>
<given-names>Y.E.</given-names>
</name>
<name>
<surname>Starkov</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Mitochondrial metabolism of reactive oxygen species</article-title>
<source/>Biochemistry
          <year>2005</year>
<volume>70</volume>
<fpage>200</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1007/s10541-005-0102-7</pub-id>
<pub-id pub-id-type="pmid">15807660</pub-id>
</element-citation>
</ref>
<ref id="B159-antioxidants-08-00436">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>How mitochondria produce reactive oxygen species</article-title>
<source/>Biochem. J.
          <year>2009</year>
<volume>417</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id>
<pub-id pub-id-type="pmid">19061483</pub-id>
</element-citation>
</ref>
<ref id="B160-antioxidants-08-00436">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakamaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Akazawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Izumino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takino</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Urata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations</article-title>
<source/>Diabetes
          <year>1999</year>
<volume>48</volume>
<fpage>1138</fpage>
<lpage>1144</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.48.5.1138</pub-id>
<pub-id pub-id-type="pmid">10331421</pub-id>
</element-citation>
</ref>
<ref id="B161-antioxidants-08-00436">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buse</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Hexosamines, insulin resistance, and the complications of diabetes: Current status</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2006</year>
<volume>290</volume>
<fpage>E1</fpage>
<lpage>E8</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00329.2005</pub-id>
<pub-id pub-id-type="pmid">16339923</pub-id>
</element-citation>
</ref>
<ref id="B162-antioxidants-08-00436">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegab</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Neyses</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mamas</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Role of advanced glycation end products in cardiovascular disease</article-title>
<source/>World. J. Cardiol.
          <year>2012</year>
<volume>4</volume>
<fpage>90</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.4330/wjc.v4.i4.90</pub-id>
<pub-id pub-id-type="pmid">22558488</pub-id>
</element-citation>
</ref>
<ref id="B163-antioxidants-08-00436">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhuri</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bains</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gugliucci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kapahi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality</article-title>
<source/>Cell Metab.
          <year>2018</year>
<volume>28</volume>
<fpage>337</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2018.08.014</pub-id>
<pub-id pub-id-type="pmid">30184484</pub-id>
</element-citation>
</ref>
<ref id="B164-antioxidants-08-00436">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schieber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chandel</surname>
<given-names>N.S.</given-names>
</name>
</person-group>
<article-title>ROS function in redox signaling and oxidative stress</article-title>
<source/>Curr. Biol.
          <year>2014</year>
<volume>24</volume>
<fpage>R453</fpage>
<lpage>R462</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id>
<pub-id pub-id-type="pmid">24845678</pub-id>
</element-citation>
</ref>
<ref id="B165-antioxidants-08-00436">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Cederberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wentzel</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Congenital malformations in offspring of diabetic mothers-animal and human studies</article-title>
<source/>Rev. Endocr. Metab. Disord.
          <year>2003</year>
<volume>4</volume>
<fpage>79</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1023/A:1021879504372</pub-id>
<pub-id pub-id-type="pmid">12618562</pub-id>
</element-citation>
</ref>
<ref id="B166-antioxidants-08-00436">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roest</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>van Iperen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wisse</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Poelmann</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Steegers-Theunissen</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Molin</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Gittenberger-De Groot</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine</article-title>
<source/>Birth Defects Res. A
          <year>2007</year>
<volume>79</volume>
<fpage>231</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20341</pub-id>
</element-citation>
</ref>
<ref id="B167-antioxidants-08-00436">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Culshaw</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Savery</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>N.D.E.</given-names>
</name>
<name>
<surname>Copp</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Mouse whole embryo culture: Evaluating the requirement for rat serum as culture medium</article-title>
<source/>Birth Defects Res. A
          <year>2019</year>
<pub-id pub-id-type="doi">10.1002/bdr2.1538</pub-id>
<pub-id pub-id-type="pmid">31237114</pub-id>
</element-citation>
</ref>
<ref id="B168-antioxidants-08-00436">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molin</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Roest</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Nordstrand</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wisse</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Poelmann</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Gittenberger-De Groot</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats</article-title>
<source/>Birth Defects Res. A
          <year>2004</year>
<volume>70</volume>
<fpage>927</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20101</pub-id>
</element-citation>
</ref>
<ref id="B169-antioxidants-08-00436">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vijaya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Manikandan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Parakalan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dheen</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Differential gene expression profiles during embryonic heart development in diabetic mice pregnancy</article-title>
<source/>Gene
          <year>2013</year>
<volume>516</volume>
<fpage>218</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2012.12.071</pub-id>
<pub-id pub-id-type="pmid">23287646</pub-id>
</element-citation>
</ref>
<ref id="B170-antioxidants-08-00436">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Dheen</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development</article-title>
<source/>Cardiovasc. Diabetol.
          <year>2007</year>
<volume>6</volume>
<fpage>34</fpage>
<pub-id pub-id-type="doi">10.1186/1475-2840-6-34</pub-id>
<pub-id pub-id-type="pmid">17967198</pub-id>
</element-citation>
</ref>
<ref id="B171-antioxidants-08-00436">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Maternal exosomes in diabetes contribute to the cardiac development deficiency</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2017</year>
<volume>483</volume>
<fpage>602</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.12.097</pub-id>
<pub-id pub-id-type="pmid">27998767</pub-id>
</element-citation>
</ref>
<ref id="B172-antioxidants-08-00436">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehtoranta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vuolteenaho</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Laine</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Koskinen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soukka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kyto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Maatta</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haapsamo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ekholm</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rasanen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2013</year>
<volume>305</volume>
<fpage>E611</fpage>
<lpage>E619</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00043.2013</pub-id>
<pub-id pub-id-type="pmid">23839525</pub-id>
</element-citation>
</ref>
<ref id="B173-antioxidants-08-00436">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohuslavova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Skvorova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sedmera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Semenza</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Pavlinkova</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Increased susceptibility of HIF-1alpha heterozygous-null mice to cardiovascular malformations associated with maternal Diabetes</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2013</year>
<volume>60</volume>
<fpage>129</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.04.015</pub-id>
<pub-id pub-id-type="pmid">23619295</pub-id>
</element-citation>
</ref>
<ref id="B174-antioxidants-08-00436">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Edelstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dimmeler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brownlee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site</article-title>
<source/>J. Clin. Investig.
          <year>2001</year>
<volume>108</volume>
<fpage>1341</fpage>
<lpage>1348</lpage>
<pub-id pub-id-type="doi">10.1172/JCI11235</pub-id>
<pub-id pub-id-type="pmid">11696579</pub-id>
</element-citation>
</ref>
<ref id="B175-antioxidants-08-00436">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baynes</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Role of oxidative stress in development of complications in Diabetes</article-title>
<source/>Diabetes
          <year>1991</year>
<volume>40</volume>
<fpage>405</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.2337/diab.40.4.405</pub-id>
<pub-id pub-id-type="pmid">2010041</pub-id>
</element-citation>
</ref>
<ref id="B176-antioxidants-08-00436">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Borg</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro</article-title>
<source/>Diabetologia
          <year>1991</year>
<volume>34</volume>
<fpage>325</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1007/BF00405004</pub-id>
<pub-id pub-id-type="pmid">1864487</pub-id>
</element-citation>
</ref>
<ref id="B177-antioxidants-08-00436">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trocino</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Akazawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Urata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagataki</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture</article-title>
<source/>Diabetes
          <year>1995</year>
<volume>44</volume>
<fpage>992</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="doi">10.2337/diab.44.8.992</pub-id>
<pub-id pub-id-type="pmid">7622006</pub-id>
</element-citation>
</ref>
<ref id="B178-antioxidants-08-00436">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Siman</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring</article-title>
<source/>Diabetes
          <year>1996</year>
<volume>45</volume>
<fpage>1497</fpage>
<lpage>1502</lpage>
<pub-id pub-id-type="doi">10.2337/diab.45.11.1497</pub-id>
<pub-id pub-id-type="pmid">8866552</pub-id>
</element-citation>
</ref>
<ref id="B179-antioxidants-08-00436">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siman</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
</person-group>
<article-title>Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats</article-title>
<source/>Diabetes
          <year>1997</year>
<volume>46</volume>
<fpage>1054</fpage>
<lpage>1061</lpage>
<pub-id pub-id-type="doi">10.2337/diab.46.6.1054</pub-id>
<pub-id pub-id-type="pmid">9166679</pub-id>
</element-citation>
</ref>
<ref id="B180-antioxidants-08-00436">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siman</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
</person-group>
<article-title>Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats</article-title>
<source/>Diabetologia
          <year>1997</year>
<volume>40</volume>
<fpage>1416</fpage>
<lpage>1424</lpage>
<pub-id pub-id-type="doi">10.1007/s001250050844</pub-id>
<pub-id pub-id-type="pmid">9447949</pub-id>
</element-citation>
</ref>
<ref id="B181-antioxidants-08-00436">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rumbold</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Crowther</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Vitamin E supplementation in pregnancy</article-title>
<source/>Cochrane Database Syst. Rev.
          <year>2015</year>
<fpage>CD004069</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD004069.pub3</pub-id>
<pub-id pub-id-type="pmid">26343254</pub-id>
</element-citation>
</ref>
<ref id="B182-antioxidants-08-00436">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rumbold</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shahrook</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Crowther</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Vitamin C supplementation in pregnancy</article-title>
<source/>Cochrane Database Syst. Rev.
          <year>2015</year>
<fpage>CD004072</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD004072.pub3</pub-id>
<pub-id pub-id-type="pmid">26415762</pub-id>
</element-citation>
</ref>
<ref id="B183-antioxidants-08-00436">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smedts</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Rakhshandehroo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wildhagen</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Verkleij-Hagoort</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Steegers</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Steegers-Theunissen</surname>
<given-names>R.P.</given-names>
</name>
</person-group>
<article-title>High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring</article-title>
<source/>BJOG
          <year>2009</year>
<volume>116</volume>
<fpage>416</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-0528.2008.01957.x</pub-id>
<pub-id pub-id-type="pmid">19187374</pub-id>
</element-citation>
</ref>
<ref id="B184-antioxidants-08-00436">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Effect of antioxidant vitamin supplementation on cardiovascular outcomes: A meta-analysis of randomized controlled trials</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e56803</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056803</pub-id>
<pub-id pub-id-type="pmid">23437244</pub-id>
</element-citation>
</ref>
<ref id="B185-antioxidants-08-00436">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Wentzel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Minhas</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Thornalley</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Teratogenicity of 3-deoxyglucosone and diabetic embryopathy</article-title>
<source/>Diabetes
          <year>1998</year>
<volume>47</volume>
<fpage>1960</fpage>
<lpage>1966</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.47.12.1960</pub-id>
<pub-id pub-id-type="pmid">9836531</pub-id>
</element-citation>
</ref>
<ref id="B186-antioxidants-08-00436">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roest</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Molin</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Schalkwijk</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>van Iperen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wentzel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.J.</given-names>
</name>
<name>
<surname>Gittenberger-de Groot</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects</article-title>
<source/>Diabetes
          <year>2009</year>
<volume>58</volume>
<fpage>1222</fpage>
<lpage>1228</lpage>
<pub-id pub-id-type="doi">10.2337/db07-1016</pub-id>
<pub-id pub-id-type="pmid">19188426</pub-id>
</element-citation>
</ref>
<ref id="B187-antioxidants-08-00436">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson</surname>
<given-names>J.E.</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Gregg</surname>
<given-names>V.H.</given-names>
</name>
</person-group>
<article-title>Exercise in Pregnancy</article-title>
<source/>Clin. Sports Med.
          <year>2017</year>
<volume>36</volume>
<fpage>741</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">28886825</pub-id>
</element-citation>
</ref>
<ref id="B188-antioxidants-08-00436">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowe</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Safdar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arany</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Running forward: New frontiers in endurance exercise biology</article-title>
<source/>Circulation
          <year>2014</year>
<volume>129</volume>
<fpage>798</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.001590</pub-id>
<pub-id pub-id-type="pmid">24550551</pub-id>
</element-citation>
</ref>
<ref id="B189-antioxidants-08-00436">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Effect of exercise during pregnancy to prevent gestational diabetes mellitus: A systematic review and meta-analysis</article-title>
<source/>J. Matern. Fetal Neonatal Med.
          <year>2018</year>
<volume>31</volume>
<fpage>1632</fpage>
<lpage>1637</lpage>
<pub-id pub-id-type="doi">10.1080/14767058.2017.1319929</pub-id>
<pub-id pub-id-type="pmid">28409688</pub-id>
</element-citation>
</ref>
<ref id="B190-antioxidants-08-00436">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mottola</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Davenport</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Ruchat</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Poitras</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jaramillo Garcia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barrowman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Adamo</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Duggan</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>No. 367-2019 Canadian guideline for physical activity throughout pregnancy</article-title>
<source/>J. Obstet. Gynaecol. Can.
          <year>2018</year>
<volume>40</volume>
<fpage>1528</fpage>
<lpage>1537</lpage>
<pub-id pub-id-type="doi">10.1016/j.jogc.2018.07.001</pub-id>
<pub-id pub-id-type="pmid">30297272</pub-id>
</element-citation>
</ref>
<ref id="B191-antioxidants-08-00436">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulkey</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Regmi</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Magnan</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Danzo</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Luther</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hutchinson</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Panzer</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Grady</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Jay</surname>
<given-names>P.Y.</given-names>
</name>
</person-group>
<article-title>The maternal-age-associated risk of congenital heart disease is modifiable</article-title>
<source/>Nature
          <year>2015</year>
<volume>520</volume>
<fpage>230</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1038/nature14361</pub-id>
<pub-id pub-id-type="pmid">25830876</pub-id>
</element-citation>
</ref>
<ref id="B192-antioxidants-08-00436">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dietz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Sattler</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Ruf</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Poppel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The influence of physical activity during pregnancy on maternal, fetal or infant heart rate variability: A systematic review</article-title>
<source/>BMC Pregnancy Childbirth
          <year>2016</year>
<volume>16</volume>
<elocation-id>326</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12884-016-1121-7</pub-id>
<pub-id pub-id-type="pmid">27784276</pub-id>
</element-citation>
</ref>
<ref id="B193-antioxidants-08-00436">
<label>193.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Moyer</surname>
<given-names>C.</given-names>
</name>
</person-group>
<source/>Influence of Exercise Mode on Maternal, Fetal, and Neonatal Health Outcomes: The ENHANCED by Mom Project
          <publisher-name>East Carolina University’s Institutional Repository</publisher-name>
<publisher-loc>Greenville, NC, USA</publisher-loc>
<year>2014</year>
</element-citation>
</ref>
<ref id="B194-antioxidants-08-00436">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newcomer</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Taheripour</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bahls</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sheldon</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Foust</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Bidwell</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Cabot</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Impact of porcine maternal aerobic exercise training during pregnancy on endothelial cell function of offspring at birth</article-title>
<source/>J. Dev. Orig. Health Dis.
          <year>2012</year>
<volume>3</volume>
<fpage>4</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1017/S2040174411000687</pub-id>
<pub-id pub-id-type="pmid">25101806</pub-id>
</element-citation>
</ref>
<ref id="B195-antioxidants-08-00436">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finck</surname>
<given-names>B.N.</given-names>
</name>
</person-group>
<article-title>The PPAR regulatory system in cardiac physiology and disease</article-title>
<source/>Cardiovasc. Res.
          <year>2007</year>
<volume>73</volume>
<fpage>269</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1016/j.cardiores.2006.08.023</pub-id>
<pub-id pub-id-type="pmid">17010956</pub-id>
</element-citation>
</ref>
<ref id="B196-antioxidants-08-00436">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pesant</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sueur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dutartre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tallandier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grimaldi</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Rochette</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Connat</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis</article-title>
<source/>Cardiovasc. Res.
          <year>2006</year>
<volume>69</volume>
<fpage>440</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1016/j.cardiores.2005.10.019</pub-id>
<pub-id pub-id-type="pmid">16337160</pub-id>
</element-citation>
</ref>
<ref id="B197-antioxidants-08-00436">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laker</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Lillard</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Okutsu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoehn</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1alpha gene and age-dependent metabolic dysfunction in the offspring</article-title>
<source/>Diabetes
          <year>2014</year>
<volume>63</volume>
<fpage>1605</fpage>
<lpage>1611</lpage>
<pub-id pub-id-type="doi">10.2337/db13-1614</pub-id>
<pub-id pub-id-type="pmid">24430439</pub-id>
</element-citation>
</ref>
<ref id="B198-antioxidants-08-00436">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species</article-title>
<source/>Oxid. Med. Cell. Longev.
          <year>2012</year>
<volume>2012</volume>
<fpage>756132</fpage>
<pub-id pub-id-type="doi">10.1155/2012/756132</pub-id>
<pub-id pub-id-type="pmid">22701757</pub-id>
</element-citation>
</ref>
<ref id="B199-antioxidants-08-00436">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Smuder</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kavazis</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Quindry</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Mechanisms of exercise-induced cardioprotection</article-title>
<source/>Physiology
          <year>2014</year>
<volume>29</volume>
<fpage>27</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1152/physiol.00030.2013</pub-id>
<pub-id pub-id-type="pmid">24382869</pub-id>
</element-citation>
</ref>
<ref id="B200-antioxidants-08-00436">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>French</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Quindry</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Upchurch</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain</article-title>
<source/>FASEB J.
          <year>2008</year>
<volume>22</volume>
<fpage>2862</fpage>
<lpage>2871</lpage>
<pub-id pub-id-type="doi">10.1096/fj.07-102541</pub-id>
<pub-id pub-id-type="pmid">18417547</pub-id>
</element-citation>
</ref>
<ref id="B201-antioxidants-08-00436">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvert</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Condit</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Aragon</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Moody</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Sindler</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Gundewar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seals</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Barouch</surname>
<given-names>L.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: Role of nitrite and nitrosothiols</article-title>
<source/>Circ. Res.
          <year>2011</year>
<volume>108</volume>
<fpage>1448</fpage>
<lpage>1458</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.241117</pub-id>
<pub-id pub-id-type="pmid">21527738</pub-id>
</element-citation>
</ref>
<ref id="B202-antioxidants-08-00436">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moens</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Barouch</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system</article-title>
<source/>J. Mol. Cell. Cardiol.
          <year>2010</year>
<volume>48</volume>
<fpage>1088</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.02.011</pub-id>
<pub-id pub-id-type="pmid">20184889</pub-id>
</element-citation>
</ref>
<ref id="B203-antioxidants-08-00436">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gude</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Muraski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kajstura</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Anversa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sussman</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population</article-title>
<source/>Circ. Res.
          <year>2006</year>
<volume>99</volume>
<fpage>381</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1161/01.RES.0000236754.21499.1c</pub-id>
<pub-id pub-id-type="pmid">16840722</pub-id>
</element-citation>
</ref>
<ref id="B204-antioxidants-08-00436">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Siegfried</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Ushio-Fukai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kojda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training</article-title>
<source/>J. Clin. Investig.
          <year>2000</year>
<volume>105</volume>
<fpage>1631</fpage>
<lpage>1639</lpage>
<pub-id pub-id-type="doi">10.1172/JCI9551</pub-id>
<pub-id pub-id-type="pmid">10841522</pub-id>
</element-citation>
</ref>
<ref id="B205-antioxidants-08-00436">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Joiner</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Skelton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Looten</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Manczak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Maternal exercise upregulates mitochondrial gene expression and increases enzyme activity of fetal mouse hearts</article-title>
<source/>Physiol. Rep.
          <year>2017</year>
<volume>5</volume>
<fpage>e13184</fpage>
<pub-id pub-id-type="doi">10.14814/phy2.13184</pub-id>
<pub-id pub-id-type="pmid">28292876</pub-id>
</element-citation>
</ref>
<ref id="B206-antioxidants-08-00436">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bostrom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Quintero</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Plovie</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Panakova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>MacRae</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rosenzweig</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling</article-title>
<source/>Cell
          <year>2010</year>
<volume>143</volume>
<fpage>1072</fpage>
<lpage>1083</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.11.036</pub-id>
<pub-id pub-id-type="pmid">21183071</pub-id>
</element-citation>
</ref>
<ref id="B207-antioxidants-08-00436">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polakovicova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Musil</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Laczo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hamar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kyselovic</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Circulating MicroRNAs as Potential Biomarkers of Exercise Response</article-title>
<source/>Int. J. Mol. Sci.
          <year>2016</year>
<volume>17</volume>
<elocation-id>1553</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms17101553</pub-id>
<pub-id pub-id-type="pmid">27782053</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="antioxidants-08-00436-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Endothelial nitric oxide (eNOS) uncoupling in states of oxidative stress. The functional eNOS dimer, producing nitric oxide, is seen on the left. eNOS dysfunction, on the right, occurs in states of oxidative stress, where BH4 is oxidized, eNOS is undimerized and uncoupled. In this state, nitric oxide is no longer produced and instead superoxide radical is generated. The salvage and de novo BH4 biosynthesis pathways are actively producing BH4 in normal conditions, but are impaired by oxidative stress, specifically derived from eNOS uncoupling.</p>
</caption>
<graphic xlink:href="antioxidants-08-00436-g001"></graphic>
</fig>
<fig id="antioxidants-08-00436-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>The Chemistry of ROS. (<bold>A</bold>) Superoxide anion (O<sub>2</sub><sup>•−</sup>) undergoes a dismutation reaction in the presence of the superoxide dismutase (SOD) enzyme, converting it into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and oxygen. (<bold>B</bold>) H<sub>2</sub>O<sub>2</sub> is then converted to secondary ROS, being hydroxyl radical (<sup>•</sup>OH) by Fenton’s reaction. (<bold>C</bold>) Hydroxyl radicals are capable of promoting the oxidation of guanosine to 8-hydroxyguanosine. (<bold>D</bold>) The hydroxyl radical is also able to react with polyunsaturated fatty acid residues of phospholipids, which are highly sensitive to oxidation, resulting in lipid peroxidation.</p>
</caption>
<graphic xlink:href="antioxidants-08-00436-g002"></graphic>
</fig>
<fig id="antioxidants-08-00436-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Possible mechanisms of hyperglycemia-induced cellular oxidative damage in the fetal heart. Excess glucose increases the rate of glycolytic metabolic pathways, overproducing electron donors that increase mitochondrial reactive oxygen species (ROS) production. Coupled with impaired antioxidant defenses including lower levels of superoxide dismutase 1 (SOD), glutathione peroxidase (GPX) and reduced glutathione (GSH), this leads to oxidative stress in diabetes. Glycolysis intermediate fructose-6-phosphate also feeds into the hexosamine pathway to produce UDP-N-acetylglucosamine (UDP-GlcNAc), which leads to impairment of endothelial nitric oxide synthase (eNOS) function by O-GlcNAc modification of eNOS at serine 1177, the site of phosphorylation by Akt activation. Oxidative stress also causes eNOS to undimerize and produce superoxide, which reacts with NO to potentiate oxidative and nitrosative stress. Additionally, advanced glycation end-products (AGEs), though binding to receptors of AGEs (RAGE) induce carbonyl stress and promote ROS. Dysfunctional eNOS and oxidative stress alter gene expression, cell proliferation, survival, and inhibit epithelial-to-mesenchymal transition (EMT), leading to CHDs, which can be ameliorated by SOD1 overexpression, and maternal treatment with N-acetylcysteine (NAC) and sapropterin (BH4).</p>
</caption>
<graphic xlink:href="antioxidants-08-00436-g003"></graphic>
</fig>
<table-wrap id="antioxidants-08-00436-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">antioxidants-08-00436-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>ROS and eNOS involvement in rodent studies on pregestational diabetes-induced congenital heart defects.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">Rodent Strain/Type of Diabetes</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">Treatment/Genetic Modification</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">eNOS/ROS Involvement</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">Altered Fetal Heart Signaling Pathways/Cellular Processes by Maternal Diabetes</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">Spectrum of CHDs in Offspring</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#B4C6E7" valign="middle">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">Swiss albino mice<break></break>STZ 75 <sup>mg</sup>/<sub>kg</sub> IP × 3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">eNOS and ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">↓ eNOS, ↑ VEGF<break></break>↓ NO release, ↑ apoptosis, cell blebbing, and aggregation *</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">N/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">[<xref ref-type="bibr" rid="B13-antioxidants-08-00436">13</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">C57BL/6<break></break>STZ 75 <sup>mg</sup>/<sub>kg</sub> IP × 3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">eNOS and ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">↑ ROS, ↓ Notch1/eNOS pathway</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">VSD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">[<xref ref-type="bibr" rid="B14-antioxidants-08-00436">14</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">C57BL/6<break></break>STZ 50 <sup>mg</sup>/<sub>kg</sub> IP × 5</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">Sapropterin</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">eNOS and ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">eNOS uncoupling<break></break>↓ proliferation, ↓ SHF contribution, ↓ cardiac valve remodeling</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">ASD, VSD, AVSD, DORV, PTA, Valve Thickening, Thin ventricles</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">[<xref ref-type="bibr" rid="B15-antioxidants-08-00436">15</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">Exercise</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">eNOS and ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">↓ eNOS phosphorylation<break></break>↓ proliferation, ↓ Wt1 expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">ASD, VSD, AVSD, DORV, HLHS, HRHS, Coronary artery malformation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#E2EFD9" valign="middle">[<xref ref-type="bibr" rid="B16-antioxidants-08-00436">16</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">C57BL/6<break></break>STZ 75 <sup>mg</sup>/<sub>kg</sub> IP × 3</td>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N-acetylcysteine</td>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↓ proliferation, ↓ Epicardial EMT</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">Coronary artery malformation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B17-antioxidants-08-00436">17</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↓ proliferation, ↑ apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ASD, VSD, AVSD, DORV, TGA, TOF</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B18-antioxidants-08-00436">18</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">SD Rats<break></break>STZ 40 <sup>mg</sup>/<sub>kg</sub> IV × 1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">Vitamin E</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">VSD, DORV, PTA, PDA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B19-antioxidants-08-00436">19</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">FVB<break></break>STZ 100 <sup>mg</sup>/<sub>kg</sub> IV × 1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">Vitamin E and Glutathione</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↑ apoptosis, ↓ CNC migration</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">PTA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B20-antioxidants-08-00436">20</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">C57BL/6<break></break>STZ 75 <sup>mg</sup>/<sub>kg</sub> IP × 2</td>
<td align="left" colspan="1" rowspan="3" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">SOD-1 overexpression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↓ Wnt/β-catenin signaling<break></break>↓ proliferation, ↑ apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">VSD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B21-antioxidants-08-00436">21</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↓ TGFb/Smad signaling<break></break>↓ proliferation **</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B22-antioxidants-08-00436">22</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↓ proliferation and ↑ apoptosis <sup>†</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B23-antioxidants-08-00436">23</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">Ask1 knockout</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↑ ASK1/JNK signaling<break></break>↑ ER stress, ↓proliferation, ↑ apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">VSD, PTA, OFT defects</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B24-antioxidants-08-00436">24</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">SD Rats, HFD +<break></break>STZ 65 <sup>mg</sup>/<sub>kg</sub> IP × 1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">ROS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">↑ lipid droplets, abnormal mitochondrial structure &amp; membrane potential</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">N/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#FFE7E2" valign="middle">[<xref ref-type="bibr" rid="B25-antioxidants-08-00436">25</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">SD Rats<break></break>STZ 40 <sup>mg</sup>/<sub>kg</sub> IV × 1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↑ apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">VSD, AVSD, DORV, DILV</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B168-antioxidants-08-00436">168</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">Swiss albino mice<break></break>STZ 75 <sup>mg</sup>/<sub>kg</sub> IP × 3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↓ proliferation, ↑ apoptosis, ↓ migration, ↓ differentiation,<break></break>↑ O-glycan biosynthesis, ↓ lysosome activity <sup>†</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B169-antioxidants-08-00436">169</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↓ proliferation, ↑ apoptosis, swollen mitochondria,<break></break>↓ myofilaments, ↓ adherence junctions</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">VSD, PTA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B170-antioxidants-08-00436">170</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">C57BL/6<break></break>STZ 50 <sup>mg</sup>/<sub>kg</sub> IP × 5</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">VSD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B171-antioxidants-08-00436">171</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">SD Rats<break></break>STZ 35 <sup>mg</sup>/<sub>kg</sub> IP × 1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↑ apoptosis, ↑ mitosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↑ heart size, ↓ cardiac function</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B172-antioxidants-08-00436">172</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">FVB Mice<break></break>STZ 100 <sup>mg</sup>/<sub>kg</sub> IP × 2</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">N/A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">↑ Hif1α/VEGF signaling<break></break>↓ proliferation, ↑ apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">VSD, ↓ myocardial volume</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;background:#F2F2F2" valign="middle">[<xref ref-type="bibr" rid="B173-antioxidants-08-00436">173</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p><bold>Abbreviations:</bold> N/A, not available; IP, Intraperitoneal; IV, intravenous; SD, Sprague-Dawley; STZ, Streptozotocin; HFD, high fat diet; SHF, Second heart field; CNC, Cardiac neural crest; ASD, atrial septal defect; VSD, ventricular septal defect; AVSD, Atrioventricular septal defect; PTA, persistent truncus arteriosus; PDA, patent ductus arteriosus; DORV, double-outlet left ventricle; DILV, double-inlet left ventricle; OFT, outflow tract; TOF, tetralogy of Fallot; HLHS and HRHS, hypoplastic left and right heart syndrome, respectively; ↑ indicates an elevation, ↓ indicates a reduction. * in vitro, ** ex vivo, <sup>†</sup> gene ontology analysis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>